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CHAPTER I
INTRODUCTION
Dioctyl sodiijia sulfosuccinate (DSS) and polaxalene (ethylene
oxidepropylene oxide polymer, Pluronic F-68
anti-constipating agents.

(R)

) are used frequently as

Combination of DSS and oxyphenistan has

been shoxm to produce jaundice in several patients (132, 16U), and it
is suspected that DSS increases the absorption of oxyphenistan and the
latter causes the hepatotoxicity.

Recently (29) it has been found

that DSS is itself absorbed and that it msy enhance the absorption of
oxyphenistan from the gastrointestinal tract.
DSS has been shown to promote the absorption of a poorly
absorbed drug, phenol red, from the colon of rats (96). In the same
study, polaxalene was shown not to have any appreciable effect on the
absorption of phenol red from the colon. However, in this study only
one concentration of the sxirfactants was used.
Since the action of surfactants on drug absorption is knoim to
be concentration dependent and because more recent reports (98) have
shown that phenol red, like most other drugs, is absorbed mainly from
the small intestine, therefore a more detailed study of the effect of
various concentrations of these s\irfactants on the absorption of
phenol red was felt necessary.

In addition, the effect of DSS on the

peritoneal absorption was also carried out.
1

2
The effect of DSS on the absorption of a poorly soluble drug,
sulfisoxazole, was also studied.
Biological Menbranes
Membranes are structures of universal occtirrence in nature.
The existence of plasma membranes and other biologic membranes is a
basic foundation of modem cellular biology, and the idea that internal
membrane systems constitute the basic cytoskeleton and circulatory
system of the cell is firmly established. Compartments are formed by
the membranes, which differ qualitatively and quantitatively in the
substances that they contain; from this it must be concluded that all
membranes possess selective permeability (57).
At the end of the last century Overton (123) suggested that a
s\ibmicroscopic lipid layer surrounds the cell and separates the cyto
plasm from the extracellular space. This assumption was based in part
on his finding that fat-soluble molecules readily penetrate into the
cell.

This dependence of the rate of penetration of a fat-soluble

substance on its lipid solubility was later confirmed by the work of
Collander (20).

Subsequently, Gorter and Orendel (56) determined the

surface area of erythrocytes and the area that would be occupied by
the lipids extracted from the membrane and sho^ied that the latter area
was twice as large as the eiythrocyte surface area.

They concluded

that erythrocyte surface is formed by a bimolecular lipid layer.
Danielli and Davson (22) in 193U proposed a membrane model: a
bimolecular leaflet composed of phospholipids on which protein molecxiles
are adsorbed. They also pointed out that these protein molecTiles mar^r
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impart structural solidity to the membrane which lipids alone could
not achieve.

The presence of a cross-linked network of polypeptide

chains, if the adsorbed proteins were to unfold themselves on the
surface of the cell, may perhaps account for the sieve-like properties
of cell meinbranes. The concept of "pores" in the membranes was first
postulated by Collander and Burland (21), and the effective diameter
of these pores has been measured indirectly in the red blood cells

(160) and in the intestinal epithelium (U6), and found to be approx
imately l;-8 Angstroms.
Since water-soluble ions, amino acids and sugars are adsorbed,
the concept of "carriers" was postulated.

Wilbrandt and Rosenberg (178)

postulated that the carrier first combines with the substrate molecule
and takes it across the membrane in some complex form which is lipo
philic in nature; this complex then dissociates at the intracellular
interface of the membrane and releases the substrate.
From studies of electron micrographs of certain membranes,
Robertson (139) modified the model of Danielli and Davson in three
ways:

(a) the number of lipid layers was limited to two, (b) instead

of being globular, the proteins were assumed to be spread on the lipid
layer, and (c) the membrane was assumed to have an assymetric structure.
Benson (10) proposed a model in which the protein is largely
globular and in the interior of the membrane to maximize hydrophobic
interactions.
bilayer-

The lipid molecules, however, are not arranged in a

Their fatty acid chains are individually intercalated into

the folds of the protein chain, with the polar heads of the lipids at
the exterior surfaces of the membrane in contact with the water. This

u
structure generated a more or less uniform complex of lipoproteins so
it is proposed that such complexes exist as morphological subunits
held together by hydrophobic interactions in the plane of the membrane.
According to Singer (1^2), lipids and proteins of membranes
are held together by non-covalent interactions and a steady state
structure is assumed.

Applying thermodynamic considerations we need

to know whether the steady state structure of the membranes is the one
with the lowest free energy.

At the molecular level, the following

general consequences of the thermodynamic considerations can be recog
nized;

(l) In order to maximize hydrophillic interactions, essentially

all the ionic, zwitterionic, and highly polar groups such as sugar
residues, which are attached to both the lipids and the proteins in
the membrane, should be in contact with the bulk aqueous phase. (2)
Models must attempt to maximize hydrophobic interactions of the entire
system of lipids and proteins in the membrane.

This involves seques

tering not only the fatty acid side chains of the lipids from contact
with water, but to the maximum extent possible, the nonpolar amino acid
residues of the proteins as well.

The interior hydrophobic region of

the membrane must be highly compact with very few holes or gaps of
atomic dimensions or larger. (3) Potential hydrogen bond donor and
acceptor groijps of proteins which are sequestered from contact with
water should form hydrogen bonds with one another to the maximum extent
possible.
The major drawbacks in structiiral features of the DavsonDanielli-Robertson (D-D-R) Model are as follows;

(l) The ionic heads

of phospholipids are largely not in contact with the bulk phase

(aqueous), but rather with the polar and ionic groups of the protein
monolayers. To account for the fact that most membranes consist of
proteins and lipids in a weight ratio considerably greater than unity,
the spread protein must essentially completely blanket the ionic heads
of the phospholipids. (2) The proteins and lipids interact with one
another and the membrane is stabilized, primarily by electrostatic
forces between their ionic groups.

(3) The protein monolayers should

exhibit a significant amount of jP-conformation (antiparallel pleated
sheet) when not in a random conformation. (U) A significantly large
fraction of the nonpolar residues of the proteins must be exposed to
the water.

In Robertson's work, evidence had been obtained only

from myelin sheaths. (6) None of the evidence so far obtained for the
bilayer form permits us to say whether the bilayer is continuous or
interrupted. (7) None of the experiments are sufficiently sensitive
and quantitative to prove whether 100 percent of the phospholipid is
in the bilayer form. It is therefore not excluded that some signifi
cant fraction of the phospholipid (perhaps as much as 30 percent) is
physically in a different state from the rest of the lipid.
It follows that this is not an arrangement which would lead to
the lowest free energy of a membrane in its aqueous environment.

The

two most serious thermodynamic problems arise because (a) the nonpolar
residues of the membrane proteins are largely exposed to, instead of
being sequestered from contact with, water molecules, and (b) the
ionic groups of the lipids and proteins are largely in contact with
one another and out of contact with water; "the burying of the ionic
grovips in a lower polarity environment is very costly in free energy"

6
(152).

The D-D-R Model, therefore, is thermodynamic ally \mlikely. The

fianction of lipids appears to be to disperse and "solubilize" membrane
proteins by a kind of detergent action, in which the hydrophobic pro
teins of the lipids and proteins interact with one another.
In the case of Benson's Model, it appears that this is in too
high a free energy state (but lower than that of D-D-R Model) to con
stitute the general pattern of organization of most of the lipids and
proteins of membranes. Intercalating most of the nonpolar fatty acid
chains among the polypeptide chains in the interior of the membrane
should, by virtue of separating the polypeptide chains, prevent the
formation of the maximum number of interpeptide hydrogen bonds (which
the fatty acid chains cannot participate in), and this would be thermodynamically \insatisfactory.
There is substantial evidence that the major portion of the
phospholipids is in bilsyer form in a variety of intact membranes.
The structures of the lipid in the membrane and of the lipid in iso
lated aqueous dispersion are closely similar. This conclusion is
st^jported by X-ray diffraction and spin label studies on similar mem
brane preparations.

So this bilsyer character of membranes rules out

models such as that of Benson.
Singer's Fluid l^fosalc Model.

Essentially on the basis of

thermodynamic considerations, together with some experimental data on
the conformation of the proteins in intact membranes, Lenard and Singer
(1^2, 1^3) proposed a hydrophobic model for the organization of the
lipids and the integral proteins (the property that distinguishes
integral proteins from others is its csqpacity to interact with lipids
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in water solutions to fom lipoprotein structures with lower free
energy than the separated lipid and protein) of the membranes.
model is also called, lipid-globular protein mosaic model.

This

The lipids

and globular integral proteins are arranged in an alternating mosaic
pattern throughout the membrane.

The hydrophobic portions of the

lipids and a large fraction of the nonpolar amino acid residues of the
proteins are sequestered from contact with water, mainly in the hydro
phobic interior of the membrane, while the ionic groups of the lipids
and the charged residues of the proteins are both in direct contact
with water, predominantly on the exterior surfaces of the membranes.
The saccharide groups whether on glycolipids or glycoproteins also are
exposed to the bulk aqueous phase of this arrangement.

Mosaic appears

to be a fluid or dynamic one and, for many purposes, is best tho\ight
of as a two-dimensional oriented viscous solution.

This model is

applicable to most functional biological membranes,
Oseroff et al. (122) recently have sv^jported this model: that
in most membranes the majority of the lipid is in the form of a fluid
bilayer matrix, and that the membrane proteins are both loosely bound
and, in some cases, deeply or transversely embedded in this matrix.
Proteins and protein-lipid complexes are probably mobile, but it is
not yet clear whether these motions result from passive diffusion or
are actively conti'olled by the cell.

Whether there exists a long range

but random order is also unclear.
Based on the results from freeze cleaving and freeze etching
the trilamellar "unit membrane" described by Robertson (138) is not
justified.

Expeidments with labelled stearate bilayers (2^) and

8
examination of both halves of the fractured specimen (17, 173) have
clearly establ3.shed that the cleavage plane tends to follovx the curva
ture of the cell stirface but passes within the membrane matrix, probably
in the midplane of the lipid bilayer.

In most membranes the fracturing

process exposes an array of particles; the density of the particles is
greatest in functionally specialized membranes, such as, retinal discs
and chloroplast lamellae; particles are completely absent in the myelin
sheath.

Other evidence that the intramembrane particles are due to

proteins intercalated into a lipid bilayer comes from work vjlth arti
ficial membrane systems. Pure lipid vesicles are lamellar phases and
show an ^sence of particles, but they appear with the addition of
erythocyte (130) and sarcoplasmic retic\iltun proteins (lOU) or with
rhodopisn (62) which definitely seemed the material of choice.
All these evidences point to the fact that Singer's model is
the best model put forward so far.
Mechanisms of Drug Absorption
Absorption is the unidirectional movement of material from
outside the body to the inside of the body. In man and other terres
trial memraals, the alimentary canal, the Itmgs, and the skin represent
the most important sites of entry for exogenous material. At each of
these sites, the movement of material takes place across epithelial
tissues that sei*ve as membranes or anatomical bari*iers.

There are

similarities in the overall processes of the translocation of materials
at these seemingly diverse barriers; the mechanisms that serve to move
materials across these membranes are those which serve to move sub
stances across any biological barrter, i.e., passive diffusion.
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facilitated diffusion, active transport, and pinocytosis; the pirinciples governing these transport mechanisms apply equally at each site;
and a substance passes through the membrane and reaches the other side,
the vascular system, the gastrointestinal, alveolar or integumental
epithelixim.

On the other side of each of these barriers substances

come in contact with fluids maintained at relatively constant composi
tion, pH, and temper at vire, and having orderly biochemical interactions.
Passive diffusion. Passive or simple diffusion does not require
expenditure of cellular energy; movement occurs in proportion to the
physical forces available, and in the same directions as the electro
chemical gradient (diffuse from a region of high concentration to a
region of low drug concentration) (7, 8U).

Most pharmacologically

important lipid-soluble drugs are transported across the biological
membranes by this process.
Gastrointestinal epitheli\im, like other biological membranes,
is essentially lipid in nature. Therefore, it permits the passive
diffusion of lipid-soluble drugs but imposes a barrier to the diffusion
of lipid-insoluble drugs.

Since most drugs are weak acids or bases,

they can exist in both the undissociated and dissociated forms in an
aqueous environment. The degree of dissociation depends on the pH of
the medi\im and the dissociation constant of the drug.

Since it is the

undissociated form of the drug that has greater lipid solubility and
hence is the more readily absorbed form of the drug, the rate of
gastrointestinal absorption of weakly acidic or basic drugs is related
to the fraction of total drug in solution in un-ionized form.

The rate

of ^sorption is enhanced when pH conditions are changed so that this
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fraction is increased.

These observations form the basis of the pH

partition hypothesis (6l, lUU, l5l), which relates the dissociation
constant, lipid solubility, pH at the absorption site with the absorp
tion characteristics of various drugs throughout the gastrointestinal
tract.
Since the stomach has a low pH, weakly acidic drugs (pKa^2.5)
exist primarily in the uii-ionized form and are readily absorbed.

Con

versely, weak bases exist primarily in the ionized form, and their
gastric absorption is negligible. Partially dissociated (very weak)
bases (pKa< 2.5) such as antipyrine and caffeine are absorbed to some
extent.

Additional evidence that it is mainly the non-ionized form of

the drug which crosses gastric eptheliiim was provided by Schanker et al.
(lU5) who demonstrated it by the reversal of the ^sorption pattern
when the gastric contents were made alkaline (pH 8.0).

Many basic

C0iT530unds become undissociated at this pH and show an increased absorp
tion rate; conversely, acidic compounds become more ionized and shov; a
decreased rate of dDsorption.

The preferential permeability of the

gastric mucosa to the non-Ionized form of drugs is further eirphasized
by the predictable manner in which drugs distribute between gastric
jtiice arid plasma.

Thus, at a steady state (constant plasma levels),

basic drugs are more concentrated in gastric juice than in plasma, and
acidic drugs are more concentrated in plasma than in gastric juice (l^l).
The pH of the fl\iid of the small intestine is approximately 6.^
and is quite high con^jared to the stomach, but it behaves like the
stomach in the absorption of drugs.

Most weak acids and bases are

readily absortedj stronger and more highly ionized acids and bases are
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more slowly absorbed; and completely ionized quatemaiy airimoni\im compotinds and sulfonic acids are very slowly absorbed.

Since pH is high

in the intestine, the absorption of weak bases is favored over weak
acids, since a large fraction of the drug is in tin-ionized form.

Still

the absorption of weak acids with pKa values greater than 3 is quite
rapid.

The large mucosal surface area available for absorption in the

small intestine appears to decrease the need for a large fraction of
the drug to be present in the un-ionized form. For example, salicylic
acid (pKa -^3) exists almost completely in the ionized form in the
intestine, but the drug is relatively well absorbed from this site
(1U9). The influence of pH on the intestinal absorption of weak acids
and bases in rats has been shown by Brodie (l6) and Kakemi et al. (6U).
Acidification of the intestinal fl\iids increases the fraction of the
drugs present in the un-ionized form and the absorption rate of weak
acids, and decreases the fraction of the drug in the \in-ioivLzed form
and the absorption rate of vzeakly basic drugs.
It has been suggested by Hogben and Schanker (6l, lU^) that the
pH of the bulk contents of the gastrointestinal tract is not a true
index of the pH on the absorbing surface.

It is proposed that a zone

with an effective or virtual pH of ?.3> possibly located at the surface
of the intestinal epithelivim, determines the degree of ionization of
drugs as they spproach the boundary to be absorbed.
The pattern of drug absorption in the colon is very similar to
that in the small intestine. However, this is not the prime site of
absorption for most drugs.
Gastrointestinal absorption of drugs is influenced not only by
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the degree of ionization but also by lipid solubility in the tm-ionized
form.

An indication that lipid solubility is the physical property

goveniing the passage of un-ionized molecules across the gastric epi
thelium has been provided by the barbiturates and the lipid-water
partition coefficients of their un-ionized form (1U8).

Kakemi et al.

(66) also have shown sixnilar correlation of partition coefficients
with absorption rate of various barbitvirates.

With a homologous series

of coirpounds this correlation of lipid solubility and absorption rate
is very significant, but the ability to make predictions concerning an
expected degree of absorption of an individual compound on the basis
of its partition coefficient is indeed very limited.

Despite this

fact, it is in general true that compounds which are highly soluble
in lipids are rapidly absorbed and those that are relatively less
lipid soluble are more slowly absorbed when no specialized mechanism
is involved in their absorption.
Facilitated diffusion.

Like passive diffusion this does not

reqtdre cellular energy, and movement occTirs only with the electrochem3.cal gradient.

It differs from passive diffusion in that the

physico-chemical properties of the constituents of the membrane and
those of solute are ins\ifficient to describe the kenitics of the pro
cess,

Therefore, the additional concept of tenporaiy combination of

the solute with a chemical structure or site, "carrier," of the mem
brane must be evoked to e^qilain the total phenomenon (8ii).

There is

increasing evidence that the protein present in the membrane plays an
important role not only in structure but in fiinction, and that proteins
are intimately involved in membrane transport (12^, 1^2, 153> 175).
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Active transport.

This process, while resembling facilitated

diffusion in that the process requires the additional concept of
carrier mediated passage across the membrane, is clearly distinguished
from facilitated and passive diffusions by the fact that a net

fltLX,

or movement, of the solute must occxir in a direction opposite to that
of the electrochemical gradient of the absorbed species.

This active

transport requires an energy source for the work to be done in moving
the solute "uphill". This process permits the cell not only to control
the rate at which substances move into, or out of, its environment, as
does facilitated diffusion, but also to control the concentration of
the specific substances inside and outside the cell. Pardee (12^) and
Whitman and "Wheeler (17^) have reviewed the progress made to isolate
these "carriers" in active tranqjort processes.
The various active transport processes known to exist in the
gastrointestinal tract are primarily associated with the absorption of
nutrtents and food digestion products (3^, 1U6).

Evidence of drugs

absorbed by an active transpoirt mechanism appears to be limited to
those agents that bear close similarity to normal body constituents.
For example, certain serine and threonine derivatives of nitrogen mus
tard and derivatives of uracil and thiamine (e.g., 5-fluoracil) have
been sho\m to be transported across the intestinal epithelium against
concentration gradients by processes that transport the parent amino
acids and pyrimidines, respectively.

Pinocytosis. This transfer mechanism also requires the expen
diture of cellular energy. It differs from active transport in that

lU
the transport of a solute, or particulate matter, is not mediated by
combination with a carrier but by the local invagination of the cell
membrane and subsequent budding off of a vesicle containing the permeant.

The poisoning by botulin toxins and allergic reactions resulting

from the ingestion of offending proteins are well known exauqjles in
htmans.

CHAPTER II

SURVEY OF LITERATURE
Rarely a drug is used in the form of a pure substance.

In

pharmaceutical products a drug is generally combined with different
types of adjuvants.

Surfactants are one of the most important groups

of the adjuvants used for diverse reasons in almost every dosage form
including liquids, semisolids, and solids.
Since these agents could affect the integrity of the biological
membranes, it has been thought that they might be effective absorption
promoters. However, it has been foimd that enhancement as well as
inhibition of absorption takes place when surfactants are added to a
drug. Blanpin (13) and Ritschel (136) have reviewed and summarized
many of these reports.

As noted by Levy (85), the difficulty in inter

preting some of these studies probably has been due to different types
of effects which surfactants can exert. Briefly, these effects include
interaction with biologic membranes and change of permeability, inter
action with the drug, interaction with the dosage form, and interaction
with the organism itself, resulting in a pharmacologic effect which
may, in turn, influence drug absorption.

Several of these effects may

be operative at the same time, some tending to enhance drug absorption,
others tending to retard it, and the net effect being dependent on the
relative magnitude of each. Gibaldi and Feldman (U9) have also recently
reviewed the major mechanisms of surfactant activity.
15
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It Is currently believed that sm-factants influence the rate
and extent of drug absorption through one or more of the following
mechanisms: (l) effect on drug solubility and dissolution rate, (2)
effect on gastric ernptying time and intestinal motility, (3) surfactant
and drug interactions, and (U) change in permeability of membranes.
The literature reports pertinent to these mechanisms are discussed
below.
Effect of Surfactants on the Solubility
and Dissolution Rate of Drugs
When a drug is administered orally in solid dosage form it
dissolves in the fluids around it; the drug in the solution form is
then absorbed by different processes, depending upon its own nat\ire
and the conditions around it (e.g., pH, food, surfactant, etc.). For
drugs which have limited solubili-ty in the booty- fluids at the absorp
tion site, the dissolution rate of the drug becomes the rate-limiting
step in their absorption. If the dissolution process at the solidliquid interface is rate limited by diffusion from the very thin layer
of saturated solution at the solid surface into the bulk liquid, then
Noyes-^i/hitney (equation 1) and Noyes-Nemst (equation 2) equations are
valid:
II = K(Os - C)

(1)

where dC/dt is the dissolution rate of a drug, Cg is its sat\irated
concentrations, C is the concentration at the time t during dissolution,
S is the s\irface area of the solid, D is the diffusion coefficient, h
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is the thickness of the diffusion layer, and V is the volume of dis
solution medium (77)•
According to dissolution theory, two important parameters
determining the rate of dissolution of a solid in a given solvent sys
tem are;

the solubility of the drug in that system, and the surface

area of the drug exposed to it. It can readily be seen from equations
(l) and (2) that, for relatively water-insoluble drugs, the solubility
term Cg is one of the most in^jortant factors governing the rate of
dissolution. Therefore, any change in the dissolution media wiiich
•v/ill effectively increase
tion rate of the drug.

should, in theory, increase the dissolu

One means by wliich this can be, and is accom

plished, is by the addition of a surfactant to the dissolution media.
The mechaiisms by which surfactants increase the dissolution
rate of a relatively water-insoluble drug are by decreasing the interfacial tension between the drug and the dissolution medium, thus
alloTTing the latter to wet the drug more conpletely and/or by means of
micellar solubilization.

The latter mechanism involves the incorpor

ation of the water-insoluble material into micelles (aggregates com
posed of monomers of the surfactant) formed above the critical micelle
concentration (CMC) of the surfactant (8).

The enhanced solubility of

a drug in a micellar solution of surfactant should result in a propor
tional increase in the dissolution rate. TiiJhile exact proportionality
is never realized in practice (because of the failure of the NoyesV;hitney equation to account for changes in the effective diffusion

coefficient of the drug), the increase in apparent solubility will
usually resxilt in an increase in dissolution rate (ii9).
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The dissolution rate of a dru^, regardless of the dissolution
mediTom, is always directly proportional to the effective stirface area
of the drug avail^le to the dissolution medium.

The effective siirface

area of a drug is usually much smaller than the specific surface area,
which is an idealized in vitro measurement.

Many drugs whose dissolu

tion characteristics cotild be improved by particle size reduction are
extremely hydrophobic and may resist wetting by gastrointestinal flxiids.
Therefore, the gastrointestinal fluids may come in intimate contact
with only a fraction of the potentially available surface area. The
effective surface area of hydrophobic drugs can often be increased by
the addition of a surfactant to the formulation, which functions to
reduce the interfacial tension between the solid and the gastrointes
tinal fluids.

Reduction in interfacial tension permits more intimate

contact of drug and fluids, thereby increasing effective surface area
and dissolution rate (U9).
Importance of dissolution rate in the absorption of drugs is
reflected in the observation by Wagner et al. (170) that blood levels
after oral administration of four different commercial brands of
warfarin showed a strong correlation with their in vitro dissolution
rates. Bass et al. (6) have shown that availability of tetracycline
is decreased almost ^0 percent from commercial capsules when 2 gm of
sodium bicart)onate was administei?ed at the same time.

When tetracy

cline was dissolved prior to administration, no differences in avail
ability were observed with or without the concomitant administration
of sodium bicarbonate, indicating that the dissolution rate step is
involved in the decreased absorption of tetracycline capsiiles.

The
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biologic availability of several conimercial digoxin tsiblets of known
low and high therapeutic potencies and of digoxin dissolved in alcohol
was studied in digitalized patients and compared with the dissolution
rates of the tablets (l6l). Biologic availability was estimated bymeasuring the area beneath the plasma digoxin cxirve.

The bioavail-

dDility of the "low potency" t^let was markedly inferior to that of
the "high potency" tablet, which did not differ significantly from that
of digoxin in alcoholic solution.

A significant correlation between

bio avail^ility and the dissolution rate was found. Llndenbaum and
Butler (92) have also studied the bioavailability of digoxin tablets
in humans after single 0,5 mg doses and in the steady state after 8-10
days of drug administration.

Excellent correlations were observed

between dissolution rate and bioavailability.

Variation in digoxin

bioavailability appears to result from differences in the rate at which
the tablets go into solution in the gastrointestinal tract. The U.S.P,
XVIII interim revision has recently changed the reqtiirements from a
disintegration test to a dissolution rate test for digoxin t^lets
based on the ^ove findings on bioavailability data.
Kellner (79) showed that higher blood cholestrol levels in
rabbits could be achieved by administering cholestrol and polysortiate

80 than by administeiring cholestrol alone. The reason for this marked
increase in cholestrol absorption could be the increased dissolution
rate of the water-insoluble compound.

Allawala and ftLegelman (2) found

the activity of solubilized iodine preparations, using polyoxyethylene
glycol nonylphenal as the solubilizing agent, also to be controlled by
the concentration in the aqueous phase which, in turn, depends on the
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relative concentrations of iodine and surfactant and the distribution
of iodine between the micellar and aqueous phases.

Fuchs and Ingel-

finger (U?) found that sodium lauryl sulfate hastened the appearance
and increased the levels of vitamin A in the blood of humaii subjects.
It has been reported that the absorption of carotene (a precursor of
vitamin A) is more rapid when solubilized in solutions of polysorttate

80 than -when administered orally or intramuscularly in oil (16?)• Sobel
(1^7, 1^8) has revealed inproved absoiption of vitamin A itself when
in solubilized form; the transfer of the vitamin to the milk of nursing
mothers is stKjerior in such case. Kakemi et al. (69) also have shown
that the absorption rate of vitamin A from the rat intestine is in
creased in the presence of polysorbate 80. MCtnzel observed that vita
mins A, D and E were absorbed more effectively from sterile surfactant
solutions than from oily solution on parenteral administration (112).
Sodium lattryl sulfate improved the blood levels of griseofulvin (which
is poorly and irregularly absorbed) (13U). The polyene antibioticj
aii5)hotericin B, is poorly soluble in water at neutral pH.

A soliibilized

preparation, enqsloying sodium deocycholate as solubilizer gives better
absorption and less pain than when administered intramuscularly as sus
pension (31)«

The percutaneous absorption of esterone is enhanced idien

the steroid is solubilized in a surfactant.

Using the potency of an

oily solution injected subcutaneously as having an activity equal to
1.0, Sjoblom (1^^) found the percutaneous activity in female mice of
solubilized preparations containing moderate concentrations of surfac
tants to be 0.36 ± 0.02 coTtQjared to a value of 0.13 ± 0.02 when solu
tions of esterone in oil were \ised.

Sjoblom (1^6) has also conducted

studies on estradial-l? and found similar results.
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Span 60 (sorbitan monostearate) and Atlas G-216U (polyoxyethylene propylene monostearate) have been shovm to increase the absorption
of sulfathiazole from a lanolin-petrolatum base (l^O).

It is not

possible to decide whether this is due to a solubilization effect or
a simple miscibility effect.

However, it is knoiwn that surfactants

increase the solubility of soluble sulfonamides in ointment bases,
^•fliitvrorth and Becker (176) have studied the effect of Arlacel 83 (Span
83 or sorbitan sesquioleate) on the solubility of sulfacetamide sodim
and s\ilfathiazole sodivan in liquid petrolatum and cottonseed oil bases.
Arlacel 83 increased the diffusion of both drugs from the cottonseed
oil base; from the petrolatum base the highest concentrations of the
surfactant decreased the diffusion process.

It is obvious that the

solubility of a drug in the base is an important factor.

Solubiliza

tion of the drug in the bases will increase "Uie satoiration of the drug
in the base, and will tend to promote its diffusion from the base,
hence increase the absorption (31)*

Incorporation of sodium la\iryl

sulfate in G-strophanthin tablets resulted in an increase in absorption
both rectally and orally in dogs, guinea pigs, rabbits, and rats.

This

is attributed to an increase in solubility and a higher rate of disso
lution of the drug in the presence of the surfactant (36).

G-strophan-

thin in a dose of 1 mg/kg, which has no effect on guinea pigs when
given rectally, actually exhibits a toxic effect on addition of sodiiim
lauryl siilfate (136).
Addition of hydrophilizing agents to tablet preparations leads
indirectly to improved absorption, since the stirfactants used not only
lead, as a result of the in^iroved wetting, to faster dissolution and
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hence to faster release of the drug from the preparation, but can also
give better distribution (13^). Chodkowska and Krowozynski also fo\md
the enhancing effects on absorption when siirfactants were included
into a tablet formulation (l8).
In some cases a surfactant msy inhibit the absorption of a
compo-und by formation of a less soluble compound. Hudson et al. (63)
reported that sitosteral and cholestrol formed a 1;1 mixed crystal or
solid solution, which has a sol\ibility only one-third that of cholestrol
in methanol, and a reduced solubility compared with cholestrol in
aqueous sodium oleate or sodium deoxycholate solutions.

This may

possibly e:cplajji the hypocholestremic effects of sitosteral in human
beings.

Solubilization of salicylic acid (91), normally a well ab

sorbed drug, led to a decrease in activity restilting from a lower level
of absorption.
Gantt et al. (h8) studied the influence of polysorbate 80 on
the absorption of spironolactone when administered orally and found
that the former markedly improved the absorption of the spironolactone;
increase in dissolution rate due to solubilization and/or wetting ef
fects is one explanation of the obseirved effects. However, changes in
the formulation and manufacttire of the dosage form upon incorporation
of the svirfactant may have been a factor in enhanced sibsorption.

A

study was performed by Cid and Jaminet (19) concerning the effect of
some surfactants, such as polysorbate 80, on the gastrointestinal
absorption of aspirin in man.

A significant increase in blood levels

of the salicylate was observed after administration of aspirin tablets
containing the surfactant.
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The behavior of stilfisoxazole in surfactant solutions has been
studied by Kakenii et al. (72).

V/hen sulfisoxazole was administered in

the form of suspensions containing varying concentrations of polysorbate 80, it was found that the blood levels after one hour increased
with increasing concentrations of the surfactant 153 to a maximum polysorb ate 80 concentration of 20 percent, the concentration which com
pletely solubilized the excess drug.

Con^arisen of relative drug

solubility in surfactant solutions and relative blood levels indicates
that 18-fold increase in s\ilfisoxazole solubility in the presence of
20 percent polysorbate 80 resulted in a threefold increase in initial
blood levels compared to the level following the administration of the
control suspension.

Above 20 percent concentration of polysorbate 80,

the rectal absorption decreased due to the entrapment of the driig in
the micelles.
Surfactants are often used as emulsifiers and solubilizers in
oily base suppository formulations. Their addition is presiimed to
affect the drug absorption to some extent from rectm. Kakemi et al.
(75) have investigated the effect of various types of surfactants on
rectal absorption of svilfisoxazole from cocoa butter. Blood levels of
sulfisoxazole were, in general, increased with increasing concentrations
of surfactant, but decreased with higher concentrations.

Surfactants

accelerated the release of the drug from the base to the medi"um, but,
on the other hand, surfactants reduced the absorption rate of the drug
from aqueous solution as noted earlier (72). The use of lipophilic
Spans, either alone or in combination with hydrophilic Tweens, increased
the release of active ingredient, aminopyrine, from suppositories (78).
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Similarly, Parrott (126) has found that aspirin was rapidly released
from suppositories of polyethylene glycol and polyoxyethylene sorbitan
monostearate base. Hanks et al. (58) also investigated the influence
the surfactants, polysorbates and sodium lauryl sulfate, on the release
and activity of chloramphenical from the suppositories prepared with
polyethylene glycol 1^00.

Optimal activity and release were obtained

with sodium lauryl sulfate. LovTenthal and Borzellaca (97) observed
faster absorption v/ith Tween 6l in the investigation of the rectal ab
sorption of salicylic acid from various suppositories bases. It has
also been shovm in the case of barbiturates that the rectal absorption
is increased by the addition of non-ionic surfactants (U3)«
As mentioned before, relatively water-insoluble drugs are solubilized by the process of micellization.

Micelles containing a drug*

when surrounded by the biological fl\iids, are able to release the drug,
depending upon the partitioning behavior of the im-ionized species of
the drug.

Water-insolxible drugs, solubilized by micellization, are

better absolved than when they are administered in the form of a sus
pension or a solid dosage form, because of the slow dissolution rate.
The phenomenon of micellar solubilization from the latter dosage form
has been reviewed by Swarbrick (l6U) and Mulley (111). Elworthy et al.

(31) have published a book on this subject.

Numerous exanples have

been cited of the pharmaceutical applications of micellar soliibilization.
A number of studies have attempted to quantitate the relation
ship between drug solubility in micellar solutions and dissolution
rates. Taylor and Wurster (I66) found that sodium dodecyl sulfate
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svibstantiaJLly increased the rate of solution of prednisolone.

Bates

et al. (8) reported substantial increases in the dissolution rates of
griseofulvin and hexestrol in micellar solutions of bile salts. Bates
et al, (9) have also shown that physiologic concentrations of lysolecithin produced marked increases in the solubility and dissolution
rates of hexestrol, dienestrol, and griseofulvin. Kuroda (83) noted
that the poor rate of dissolution of benzoic acid is improved in the
presence of polysorbates 20 or 80. Parrott and Sharma (12?) have also
found increase in the dissolution rate of benzoic acid in the presence
of surfactants:

tyloxapol, polysorbate 80, sodium lauryl s\ilfate and

polaxakol. These surfactants only slightly improved the dissolution
rate below their critical micelle concentration (CMC) due to improved
wetting of surface.

But at concentrations exceeding the CMC, the dis

solution rate increased with increasing concentrations of the svirfactants.

Elworthy and Lipscomb (32) studied the dissolution rate of

griseofulvin in water and aqueous solutions of foxir non-ionic surfac
tants and found that the latter increase the dissolution rate of the
drug.

Gibaldi et al, (52) studied the influence of polyoxyethylene

[23] lauryl ether, a non-ionic surfactant, on the dissolution rate of
benzoic acid and salicylic acid and fotund that the dissolution rate
was increased in the micellar solution. Influence of surfactant
micelles (polyoxyethylene lauryl ether) on the dissolution of salicylic
acid from constant-surface pellets has

been studied (5l) and the rate

of dissolution was found to increase.
While the influence of micellar solubilization on dissolution
rate has been st\idied extensively, the effect of low concentrations
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(belov the CMC) of surfactants on the dissolution of drugs from powders
and other solid dosage forms has been given limited attention. Finholt
and Solvang (UU) studied the dissolution of phenacetin powder sprinkled
on the surface of O.IN hydrochloric acid containing low concentrations
of polysorbate 80.

An increase in the polysorbate 80 concentration

from zero to 0.01 percent causes a significant increase in the dissolu
tion rate.

The effect of polysorbate 80 on the dissolution rate of

phenacetin is caused mainly by its ability to reduce the interfacial
tension between the powder and the dissolution meditam.

Prescott et al.

(131) have also studied the effect of polysorbate 80 on the absorption
of phenacetin in humans given in the forms of suspensions and tablets.
In separate expei*iments individuals received phenacetin as a fine sus
pension with and without polysorbate 80, a medium suspension, and a
coarse suspension. They found striking differences in the plasma con
centrations of phenacetin depending on particle size administered.
The highest values were observed with the fine particles suspended
with polysorbate 80, followed in decreasing order by fine, medium, and
coarse particles. They concluded that pairticle size is an important
factor in the absorption of phenacetin, and also that absorption is
apparently enhanced by polysorbate 80.
Vfeintraub and Gibaldi (17U) have studied the influence of
premicellar concentration of a non-ionic surfactant (polyoxyethylene
lauryl ether) and a physiologic surfactant (lysolecithin) on the dis
solution rate of drugs from powders and from commercial dosage forms.
Polyoxyethylene lauryl ether and lysolecithin increased the dissolution
rate of powdered salicylic acid, and sodium glycocholate increased the
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dissolution rate of powdered salicylsmide.

In each case the effect

principally involved a "wetting" phenomenon rather than solubilization.
Both the non-ionic surfactant and lysolecithin enhanced the dissolution
rate of aspirin from a tablet dosage form but were without effect on
the dissolution rate of the drug from a capsule dosage form.
Effect of Surfactants on the Gastric
Emptying Time and Intestinal
Motility
In view of the qualitative and quantitative differences between
the absorption properties of the stomach and intestine, any delay in
the transfer of a drug from stomach to intestine may affect the absorp
tion rate and, thereby, the onset of therapeutic activity. For example,
a weak base such as codeine will be absorted mainly from the small in
testine rather than from the stomach, and any delay in gastric emptying
will tend to delay the onset of analgesia.

Slow gastric emptying can

also affect the biologic availability of drugs that are vinstable in
gastric fluids, the extent of degradation being proportional to the
time during which such drugs are exposed to low pH or gastric enzymes
(8^). The effect of pharmaceutical formulation ingredients on the
dissolution rate of weakly acidic drugs often will be most noticeable
while the drugs are in the stomach, where ordinarily they dissolve
relatively slowly.

Such differences msy disappear when the drugs reach

the small intestine, where dissolution is more rapid and less affected
by differences in properties of the dosage forms (87).
Delay in gastric emptying, on the other hand, can also cause
increased absorption of a drug; an example has been provided by the
work of Levy and Jusko (88). They found that administration of
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riboflavin in hxanan subjects after a test meal increased the urinary
recovery of the vitamin.

Riboflavin is apparently absorbed by a

specialized process high in the jejumum.

Since the absorption process

for riboflavin is capacity limited, the rate at which the vi tamin
passes the absorption site may have an influence on the overall extent
of absorption.

These workers postulated that since a meal reduces the

rate of gastric emptying, the rate at which riboflavin reaches the
absorption site is also reduced, resulting in an increase in the ab
sorption of the vitamin,
Siirfactant macr influence gastric eit^tying rate by direct action
on the stomach. Hardt (59) found that when sodium lauryl sulfate was
introduced in certain doses in solid or solution form into the stomachs
of dogs, it produced coif^jlete inhibition of nomal gastric motility for
periods ttp to 90 minutes.
Surfactants m?y also influence gastric emptying rate and intes
tinal transit by physically altering the viscosity of the gastro
intestinal fluids. Okuda et al. (121) studied the effects of non-ionic
surfactants on the intestinal absorption of vitamin 82^2*

They found

that three of the surfactants studied enhanced the gastrointestinal
absorption of the vitamin when the surfactants were administered \indiluted in high doses.

This enhancing effect of polysoi^ate 80, poly-

sorbate 85 (polyoxyethylene sorbitan trioleate), and G-IO96 (polyoxyethylene sorbitan trioleate) was postulated to be due to the formation
of a highly viscous mass in the gastiric and intestinal lumen which
resulted in a del^ in gastric erptying and thus increased the gastroijitestinal absorption of vitamin Bi2»
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A stirfactant rascy also exert a specific pharmacologic effect on
the gastrointestinal tract which may influence drug absorption. Dioctyl
sodium sulfosuccinate (DSS) retards gastric emptying (9U) and has an
inhibitory effect on gastric secretions, even when administered in
relatively low doses. Inhibition of gastric secretions occurs when
the drug is administered intraduodenally, but there is no effect when
contact of the drug is limited to the lumen of the stomach or when it
is administered parenterally.

It has been suggested by the author (9U)

that the inhibitory effect of DSS is mediated by a hormone released
from the intestinal mucosa, e.g., enterogastrone. Inhibition of gas
tric motility in the dog following introduction of certain detergents
into the gastric pouch was found by Necheles and Spom (11$).
The influence of bile salts on gastrointestinal motility has
also been studied. Pannett and Wilson (12U) have reported that the
addition of a small quantity of sodium taurocholate to a test meal is
folloi-ied by an ^normally rapid evacuation of the stomach contents.
They also fotind an increase in the secretion of acid in the presence
of the bile salt.

Saski (lUO, lUl) reported the effects of orally ad

ministered bile salts on the motility of the rabbit gastrointestijial
tract.

It was found that the effects of bile salts on gastric motility

were extremely variable, with a slight increase in motility noted at
low doses and a small decrease in motility at higher dosage levels of
bile salts.

The effect of bile salts on intestinal motility also was

of a small order of magnitude (lUO). The bile salts usually produced
a small increase in motility (lUl). Feldman et al. (38) have reported
the effect of orally administered bile salts on gastric emptying in
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the rat.

Using phenol red as a marker substance, it was found that

sodium deoxycholate and soditun taurodeoxycholate significantly de
creased gasti*ic enqjtying of the phenol red solution.

Gastric emptying

of phenol red in control animals was found to proceed by apparent first
order kinetics, but a very different kinetic pattern was observed upon
administration of bile salt.

Sodium deoxycholate and sodium tauro

deoxycholate also produced a large net secretion of fliiids into gastric
pouch for at least one hour after stomach intubation. It is proposed
that the resulting increase in gastric volume is the immediate cause
for the decreased rate of gastric emptying (Ip.).

Mayersohn et al. (103)

investigated the gastrointestinal absorption of riboflavin and flavin
mononucleotide (FMI) under controlled conditions and after oral admin
istration of 600 mg of sodium deoxycholate.

Increased urinary excretion

levels suggest an unusually prolonged absorption of riboflavin which
may be due, in part, to a decrease in gastric emptying time.
Smrfactants and Dinig Interactions
A significant change in the ability of a drug to permeate a
biologic membrane may result from an interaction of the drug molecxile
with the surfactant to form a molec\ilar complex.

A molecTilar complex

consists of constituents held together by weak forces, such as hydrogen
bonds.

This type of interaction is usually reversible, provided that

the complex is sufficiently soluble in the biologic fluids. The
properties of drug complexes, including solubility, molecular size,
diffusiveness, and lipid-water partition coefficients, can differ
significantly from the properties of the respective free drugs. These
differences are responsible for the fact that many drug complexes
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cannot penetrate biologic membranes, and therefore, have no biologic
activity. In such cases, the fraction of drug in the complex, which
is in equilibrium with the non-complexed drug, will be in an essen
tially nonabsorbable form and the effective concentration of drug will
be less than the total concentration.
In sinple solutions the antibacterial activity of the phenol
is logarithmically related to its concentration, but in solutions con
taining surfactants at concentrations high enough to form micelles,
the activity is not related to the overall concentration in solution
because the micelles compete with free water for phenol so that only
part of it is available for interaction with bacteria. The effect ma?/be regarded as a partition phenomenon, so that the concentration of
the phenol in aqueous phase depends on the "partition coefficient" of
the phenol and the ratio of the volume of the micellar "phase" to the
aqueous "phase" (ill).
Below the CMC the activity of phenols is dramatically increased
by the surfactants. This seems to be due to the increased tptake of
the phenol on the biologic menibrane by the high surface activity of a
loose cor5>lex between the phenol and the surfactant. The perme^ility
of the bacterial surface may also be increased in the presence of
surfactant. In systems where the concentration of stirfactant is kept
constant (above CMC) and the concentration of phenol is increased
(i.e., capacity of the system is fixed) one would expect activity to
increase regularly since both micelles and aqueous "phase" are being
progressively saturated with the phenol.

This expectation has been

proved by the work of Berry and Briggs (11), who have shown that all

32
phases in a system like this will be in eqtiilibri"um and the concentra
tion of phenol "free" in the aqueous phase will increase in the same
proportion as that in the micelles.

A gro'i-rbh inhibition study of hex-

etidine (bis-1, ^-ethylhexyl-5-amino-5-methyl [hexd^ydropyrinidine])
carried out in the presence of pluronic F-68, L6Li and L62 showed that
the activity was enhanced below the CMC of pl\ironic F-68 and l6U
(pluronic L62 had no effect at any concentrations) and above the CMC
the activity of hexetidine was reduced by the former compounds (lU2).
Another exanple of interaction of surfactant with the drugs is
that of iodophors. For many purposes solutions containing 1 to 2 per
cent of iodine are used, solubilized by a suitable proportion of the
siirfactant, usually the non-ionic type.

Allawala and Riegelman (2)

have shown that the proportion of iodine solubilized changes propor
tionately with the concentration of the surfactant (nonyl phenol
polyglycol ether-Antarox A-UOO). The same authors found that the
activity of solubilized iodine depended on the amount in the free
solution which is controlled by the proportion of iodine to the sur
factant and the "distribution coefficient" of iodine between micelles
and the aqueous phase.
Preservatives, like the p-hyxiroxybenzoates, have far greater
activity in aqueous solutions of surfactants below and up to their CMC,
but activity decreases dramatically beyond this point; same phenomenon
takes place as described above.

Bolle and Mii*imanoff (lU) were the

first to point out the reduced effect of methyl-p-hyxlroxybenzoate in
the presence of several structurally different non-ionic surfactants.
De Navare (27) followed vp this work and in 19^7 remarked that
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practically an non-ionic surfactants based on ethylene and propylene
oxide condensed with each other or with fatty esters, alcohols or
acids, inactivate all the preservatives considered at that time suit
able for drug and cosmetic preparations. This has been confirmed by
other workers (171). Non-ionic surfactants have been found also to
reduce the effect of quaternary ammonium compounds (137). Activity of
organic mercuiy conpounds is also markedly reduced in the presence of
non-ionic siirfactants (171). The inactivating effects of non-ionic
surfactants on the preservatives are of greater significance than those
of other types of surfactants because not only is the order of their
inactivation much higher, but, unlike the other surfactants, non-ionics
have comparatively no groirth-inhibiting properties, making the neces
sity for adequate preservation of systems containing them much greater.
Wedderb\im (172) has summarized the evidence relevant to estab
lishing the mechanism or mechanisms by which these preservatives are
inactivated in relation to their interaction with non-ionic surfactants.
Mcellar solubilization and the formation of molecular coirqplexes of the
type described by Higuchi et al. (60) have both been proved as being
responsible for their inactivation. \^ile complexation is thought to
be important in some systems, Evans (3U) has ST:^gested that the most
important factor is micellar solubilization when the non-ionic surfac
tant concentration exceeds the CMC.

The antimicrobial activi-ty of

preservatives in such systems has been shown to be directly related to
the concentration of free unbound preservative (172).
Cationic forms of chlopromazine, promethazine, tetracaine, and
methylrosaniline, and anions such as naphthalene sulfonate were bound
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•bo polysorbate 80, the degree of interaction being sufficient to suggest
that the non-ionic might have considerable influence on the st^ility
and availdaility of ionic drugs in formulations (107).
t

Studies of the effects of neortgrcin and kanairycin upon intestinal
absorption in normal but obese humans have sho-wn that both antibiotics
produce steatorrhea and are able to reduce their own intestinal absorp
tion due to the formation of insoluble, nonabsorbable precipitates with
bile salts (37).

Kakemi et al, (6$) studied the effect of sucrose

esters and other sxirfactants on the absorption of various drugs using
perfusion technique on the rat small intestine. Tetracycline, sulfa
nilamide, isoniazid, and salicylic acid were used to test drugs and
sodium lauryl s\ilfate, benzethonium chloride, polysorbate 80, sucrose
monostearate, and sucrose distearate were the surfactants used.

It

was found that ionic nature of the surfactants substantially influenced
the absorption; rate of absorption of tetracycline was accelerated by
soditim lauryl sulfate, benzethonium chloride, and sucrose esters; polysorb ate 80 showed a marked reduction in the absorption of salicylic
acid and tetracycline; benzethonium chloride reduced the absorption of
salicylic acid and sucrose esters within different concentrations
tested did not reduce the absorption of all the drugs tested.

These

were explained due to the formation of complexes or other forms of
interactions and/or by the correlation of partition coefficients.
Malone et al. (99) found a significant increase in the pharma
cological activity of reserpine in mice after oral administration of
the drug as a solid dispersion in deoxycholic acid.

A correlation

between the conposition of the reserpine-deoxycholic acid dispersion
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and biologic activity vras also noted in that an increase in the
deoxycholic acid ; reserpine ratio resvilted in an increase in blepharoptotic activity.

Gibaldi et al. (h9) suggested, on the basis of

dissolution rate studies of this system (deoxycholic acid : reserpine),
that pajrticle si7€ reduction of reserpine in the dispersions, leading
to increased dissolution and absorption rate, and possibly increased
availability of reserpine, is likely to be a major factor in the en
hancement of pharmaxiologic activity.

DeCato et al. (26) have also

studied the reserpine-bile salts coprecipitates absorption in mice.

It was shown that intravenous administration of reserpine acetate and
oral deoxycholic acid showed no increase in blepharoptotic potency
relative to Intravenous reserpine acetate alone.

Since this experiment

eliminated the physico-chemical interactions within the gastrointes
tinal tract, the authors have concluded that the potentiation of
reserpine taken orally as reserpine-bile salts coprecipitates is by
physico-chemical rather than physiopharmacological means.
Riegelman and Crowell (133) studied the effects of surfactants
on the rectal absorption of iodoform, tri-iodophenol, and iodide in
rats. Polysorbate 80 and sodlxim lauryl sulfate were foTjnd to decrease
the rectal absorption rate of iodoform and tri-iodophenol, but to in
crease the absorption rate of iodide.

The decrease in rectal absorp

tion rate of iodoform and tri-iodophenol was attributed to micellar
complexation of the drugs, while the increase in iodide absorption
rate was postiHated to be due to a cleansing action of the sxirfactant
on the intestinal mucosal surface.

Since iodide ion is lipid insoluble,

it would not be expected to be incorporated into the s\irfactant micelles.
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Retardation of iodoform and tri-iodophenol absorption in the presence
of micellar concentrations of the sxirfactants is in accord with the
following model: (a) a micellar solution consists of two phases, (b)
the partition ratio of drug between micellar phase and the aqueous
phase is constant, independent of drug concentrations, and (c) absoi*ption of the drug incorporated in the micelle is negligible. Since the
drug in the micellar phase is \inscvailable for absorption, the effective
concentration of the drug is less than the apparent concentration, and
a decreased absorption rate is observed.
Levy and Reuning (91) studied the effect of micellar solutions
of polysorbate 60 on the absorption of ethanol and salicylic acid from
the rat gastric pouch.

They found that in the presence of 2 percent

polysorbate 60 the absorption of salicylic acid was decreased from
percent in one hour to 33 percent in one hoTir, while ethanol absorption
remained unchanged.

The obseirved effect was due to a decrease in ac

tivity of salicylic acid as a result of micellar complexation.

The

absorption of ethanol (which would not be incorporated into the sur
factant micelles) was unaffected by the presence of surfactant.

Kakemi

et al. (72) studied the effect of various non-ionic surfactants on the
rectal dDsorption of sulfonamides from solutions in the rat.

At con

centrations of the surfactant aibove the Cl-IC a reduction in the absorp
tion rates of the sulfonamides was observed due to entrapment of drugs
in micelles. Ionized sulfonamides are poorly solubilized in the
micelles, but it is the un-ionized form which is biologically active
and the \in-ionized form has distribution coefficient in favor of the
surfactant micelles than the biological fluid. They also noted that
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the ionized moiety of these drugs is also able to be absort)ed to a
certain extent.

Moroshita et al. (110) also found that the absorption

from rat intestine of sulfonamides in the anionic form was quite sig
nificant.

Yamada and Yamamoto (l82) found similar effects of micellar

solutions of polysorbate 80 on the intestinal absorption of salicylamide in the perfused rat small intestine.

Also, they observed no

apparent effect of polysorbate 80 on the mucosal membrane, as deter
mined by permeability expeirLments with salicylamide before and after
a prolonged perfusion of the intestine with a polysorbate 80 solution.
It is obvious that this technique can detect only irreversible effects
on membrane permeability.

Matsumoto (101) offered essentially the

same mechanism of micellar solubilization and a corresponding decrease
in free drug concentration to explain the effect of polysorbate 80 on
the intestinal absorption of stilfisoxazole in the rat.

Saski (lUl)

studied the effect of micellar solutions of tyloxapol, a non-ionic
svirfactant, on the transfer of hydrocortisone across everted rat intes
tine.

Drug transfer rate was inversely proportional to the surfactant

concentration and the viscosity of the solution tested.

The data sug

gest that the membrane is in^ierme^le to the drug-micelle species.
Utsumi (l68) found that sodium lauryl stilfate formed a complex with
benzoylthiamine disulfide (BTDS) through ionic and hydropholic inter
action, and decreased the absorption rate of BTDS from rat intestine.
But it was fotaid later by the same authors that a system containing
both sodituti lauryl sulfate and sodium glycocholate reversed the decrease
in absorption rate of BTDS vq) to around the control level. By deter
mining the saturation solubility of BTDS it was found that its

38
solubility in 0.2.% sodium lauryl sulfate solution was remark^ly re
duced by mixing sodium glycholate in this solution. In this binary
surfactant mixture an increase in the CMC value with decreasing parti
tion coefficient for BTDS in the micelles was found in proportion to
the increase in the ratio of sodium glycocholate and sodivim lauryl
sulfate.

The authors have concluded from this that sodium glycocholate

contributes to creating new mixed micelles having a different partition
coefficient from the drug (BTDS) than from those of sodixui lauryl sul
fate micelles.

The formation of mixed micelles and the ensuing in

crease in the amo\ant of BTDS out of micelles are evidenced to be
responsible for the sodium glycocholate effect which cancels the
inhibitory action of sodium lauryl sulfate in the absorption of BTDS.
Influence of Sm^factants on the
Permeability of Membranes
A nuniber of siobstances have been found to 'interact' with
biological membranes and thereby alter permeability or transport char
acteristics.

Windsor and Cronheim (180) reported that heparan and

s\ilfopolyglycine, normally very poorly absorbed from the gastrointes
tinal tract, were absorbed to an apprecistole extent when axJministered
together with the chelating agent, ethylenediamine tetra-ajcetic acid
(EDTA).

Schanker and Johnson (1U7) also observed an increase in the

in vivo intestinal absorption of mannitol, inulin, a quaternary ammon
ium conpovmd, and sulfanilic acid (all lipid insoluble compounds) in
the presence of EDTA.

Tetracycline has also been shown to interact

with the biologic membrane mediated through calcium ions (67, 113).
Tetracycline increased the absorption of sulfanilic acid and
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sulfaguard-dine (llU). Nadai et al. (llU) have examined the histological
changes occurring in the rat small intestine (using light microscope
and scanning electron microscope) after administration of EDTA, which
has absorption enhancing effect on the poorly absorbable drug.

Marked

separation of epithelial cells was observed but histological changes
were not obseirved as viewed with light microscope.

The role of calcium

in maintaining the integrity of the intestinal membrane was affected
by the chelating agent and the removal of calcium ion from the intes
tinal mucosa caused such marked shedding of epithelial cells.
Surfactants may also be cspable of modifying the properties of
biologic membranes.

Perhaps the earliest report of the effect of sur

factant on drug activity is that of Billard and Dieulafe (12), who
noted that the toxic effect of ctirare injected intraperitone ally into
guinea pigs could be increased by the addition of low concentrations
of soap and decreased by high concentrations.

Alexander and Trim (l)

reported that the penetration of hexylresorcinal into Ascaris lunibricoides can be affected by cetyltrimethyl ainmont\im bi^mide (CTAB) in two
different ways. Below the CMC the surfactant increased the penetration
of the drug, and at concentrations above CMC, the penetration of the
drug was reduced.

Effect of surfactant below CMC is due possibly to

the increased permedsility of the membrane surface.

Levy et al. (89)

studied the effect of polysorbate 80 on the absorption of a number of
barbitiirates across the goldfish membranes.

The absorption rate of

barbiturates was found to increase significantly in the presence of
low concentrations (below CJKJ) of the surfactant and to decrease at
higher concentrations of the surfactant. Their fiirther studies (86)
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showed that the increase in absorption rate of secobarbital at the
concentrations of polysorbate 80 below the CMC vxas due to an increase
in the permeability of the biologic membranes rather than to formation
of a more rapidly absorbed non-micellar polysorbate:
conplex.

secobarbital

The same authors (3) ha^e also shotm that pre-micellar con

centrations of polysorbate 80 enhance the absorption and exsoiption of
U-aminoantipyrine across the goldfish membranes.

Gibaldi et al. (53)

studied the influence of sodiura taurodeoxycholate on the pharmacologic
effect (overt\im time) of pentobarbital and ethanol in goldfish.

They

found that bile salt significantly potentiated the pharmacologic effect.
Ethanol can diffuse through the 'pores' of the membrane, while the
barbiturate must diffuse across the lipoidal barrier; the non-ionic
surfactant might have a specific effect on the lipoid content of the
cell membrane and thus change its permeability. Further studies (11?)
indicated that the bile salt exerts an all-or-none effect on the tiptake
of U-amino antipyrine in goldfish; an alteration in membrane permea
bility was observed above a certain bulk concentration but below the
C14C of the stirfactant.

Whitworth and Yantis (177) found an increase

in the absorption of salicylic acid across the external membranes of
the frog in the presence of 0.1^ polysorbate 80.

The effect of poly

sorbate 80 on the biological activity of chloipromazine hydrochloride
in solution was investigated by Florence (U5) using the goldfish.
Below a certain critical concentration the activity was enhanced in
unbuffered drug solutions, but above this concentration the activity
was diminished, possibly due to some association between sxirfactant
micelles and drug molecules.
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Hunan cornea has also been used to study the effect of surfac
tants on absorption. In such a study (lOO) 0.1% solutions of non-ionic
surfactants were used.

The permeability of the cornea was measured by

following the movement of the fluorescein dye.
(Tween 20, Brig
tion of fluorescein.

Only three surfactants

and Brig 58) had any marked effect on the absorp
Tween 20 was the only coir^Jound that safely in

creased the permeability of the corneal epithelium; the other two
agents produced eye irritation.
Nickel salts compounded with anionic stirfactants caused edema,
but non-ionic and cationic siirfactants did not show this effect.

This

could be due to an acanthotic effect (modification of the prickle cell
layer [strattmi germinativum] of the skin) or to the denaturation of the
epidermal proteins by the anionic surfactants, allowing nickel salts
to penetrate skin and cause eczema (l69).

Scala et al. (lU3) in a

study of the percutaneous absorption of ionic surfactants found that
alkylbenzene sulfonates and dodecyltrimethyl ammonium chloride alter
skin permeability as they diffuse into and through the skin.

When

nicotinate and thiourea were placed in the surfactant solution, the
rate of diffusion of these coir^ounds was found to increase with time,
similar to the diffusion characteristics of the surfactants themselves.
Kay (78) found that the permeability of the Ehrlich-Lettre ascites
carcinoma cells was increased greatly in the presence of polysorbate
80 as sho^Tn by the tptake of Lissamine green dye. Percutaneous ab
sorption was measured by immersing the hind foot of a mouse in a drug
solution, then extracting the d3soit)ed drug.

It was shown that poly

sorbate 80 increased pyrrolnitrin sibsorption when a surfactant con
centration of 0.01^ and 0,\% was used.
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Appel (5) foiind that simultaneous feeding of sodium lauryl
sulfonate and inulin to rats results in up to a tenfold increase in
urinary excretion over control values.

The enhanced urinary excretion

of urine may be the resiJ.t of an increase in intestinal permeability
to inulin in the presence of the surfactant. Mori et al. (109) found
that rats and hamsters fed polysorbate 20 showed increased gastro
intestinal absorption of iron. However, Brise (l5) in a later study
reported that there was no effect of polysorbate 20 on iron absorption
in man.

He further postulated that the increase in the absorption of

iron in hamsters and rats in the presence of polysorbate 20 by Moi-i et
al. may have been due to some 'toxic' action of the surfactant. The
absorption of barium chloride ingested by cats was promoted by both
polysorbate 20 aid sodium lauryl sulfate at low concentrations and
inhibited at high concentrations (1^9).
Suzuiki et al, (162) found increased permeability, as measured
by a circulating dye, at the site of an intracutaneous injection of
various non-ionic surfactants.

Authors postulated that this increase

was mainly due to the wetting and solubilizing effects of the surfac
tants on lipid structure of the capillary wall.

Matsuzawa et al. (102)

studied the effect of some non-ionic surfactants on the muscular ab
sorption of endtiracidin.

Addition of the surfactant remarkably pro

moted the absorption of enduracidin from the muscles of the rats.

They

postulated that since the effects of surfactants are considered to be
due to their interaction with both the biological membrane and the
drug, therefore it is reasonable to sippose that one of the enhancing
effects observed could be attributed to the surface tension lowering
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of the biological raeiribrane, which allows the ready passage of the
antibiotic through the muscles.
Penzotti and Mattocks (128) found an increase in the rate of
peritoneal dialysis of urea and creatinine in rabbits in the presence
of siirfact ants. It was found that the order of magnitude of effects
decreased in the following manner:

cationic > anionic >> non-ionic.

It appears that the mechanism involves a change in the permeability of
the peritoneal membrane.
Lish and Weikel (96) studied the effects of surfactants on the
absorption of an anionic dye, phenolsulfonphthalein (PSP) from the
colon of rats. Both sodium lauryl sulfate and dioctyl sodium sulfosuccinate, but not the non-ionic Pluronic F-68, increased the absorp
tion of PSP-

None of the surfactants studied had any effect on the

absorption of the cationic dye, methyl violet. Engel and RLggi (33)
studied the effects of surfactants on the intestinal absorption of
heparin in the rat. They found that intraduodenal administration of
heparin with either sodium lauryl sulfate, dioctyl sodium s\ilfosuccinate, or G-300 (an alkyl aryl sulfonate) resulted in an increase in
heparin absoiption over that observed when heparin was administered
alone. They also reported enhanced heparin absorption in the presence
of O.U^ sodium taurocholate. The authors postulated that the increase
in heparin absorption is due to an effect of the surfactant on the
intestinal mucosa.

Kakemi et al. (69) studied the absorption of solu-

bilized vitamin A (in surfactant) from the rat intestine.

Contrary to

the notion that the only form in which drug can penetrate the membrane
is the free form of the dinig, both vitamin A acetate and vitamin A
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alcohol, entrapped almost completely in the micelles, were absorbed
fairly well from the small intestine, but not as from the large intes
tine. It was demonstrated that in the very early stages of dasorption,
vitamins sol\jbilized in micelles are absorbed onto the membrane, which
is favored by the surfactant, and this results in a local build-up of
concentration of the vitamins.
through the membranes.

This process makes the drug transport

Kakemi et al. (70) studied the absorption of

drugs from oil in water emulsions from the rat large intestine. It was
found that in the case of poorly oil-soluble drugs the absorption was
increased when administered in the form of emulsion; but in case of
drugs of low lipophilicity the absorption was inhibited when emulsion
volume was kept constant in both cases.
Davis and Kreutler

(2I4.)

studied the effect of surfactants on

the absorption of water-soluble substances from rats.

Using labelled

cyanocobalamin (^'''co) both gastric and intestinal absorption were
markedly increased by the addition of Brij 98 (polyoxyethylene-20olelyl ether) to the aqueous solution of the vitamin.

Absorption of

cephaloridine and cephalothin was promoted both in ligated stomach and
ligated small intestine.

Using cholestrol monolayers Gillan and Flor

ence (^U) have found that, in case of non-ionic surfactants, where the
surfactant has long hydrophile chains (i.e., > ^ ethylene oxide units)
rather than a single ethylene oxide chain or several short ethylene
oxide chains, drug absorption rates would not increase. This indicates
that the effectiveness of the surfactant is due to the ease with which
the surfactant molecule penetrates lipid membranes.

Bile salts hmre long been implicated in the intestinal
absorption of fat and other nutrients. They are knov/n to have
an important role in the eraulsification of water-insoluble,
long-chain triglycerides and in stimulating the action of
pancreatic lipase, resulting in a mixt\ire consisting of fatty
acids, monoglycerides, diglycerides, and triglycerides. A
powerful emulsifying agent is also formed by removal of a
fatty acid moiety from a molecule of lecithin by a pancreatic
phospholipase to give lysolecithin (I4.9).
Bile salts have also been shown to be involved in the absorption of
vitamins A, D, and K.

Several reports have shown the effect of bile

salts on the absorption of cholestrolj exogenous bile salts also en
hance the absorption of cholestrol (U9).

A recent report has sho^-m

that bile salts increased about 25 percent the absorption of labelled
dietary cholestrol fed to germ-free rats (177)•

Longemann and Dobbins

(U9) found that intraperitoneal injections and large oral doses of
sodium taurocholate enhanced the absorption of calcium by the rat.
Seyfried and Lutz (h9) reported that the absorption of tetraiodophenolphthalein from intestine was greatly diminished in the absence of
bile salts. Pekanmaki and Sabin (U9) reported that the absence of
bile from the intestine of cats reduced the absorption of phenolphthalein,

Davenport (23) found that bile salts are capable of increas

ing the perme^ility of the gastric mucosa as judged by hydrogen ion
flux. ^Vhen sodium deoxycholate was administered 30 minutes prior to a
dose of riboflavin, a ^0-80 percent increase in total urinary recovery
was found. Two mechanisms were postulated by the authors: (a) reduc
tion in gastric emptying time, and (b) increase in the permeability of
gastric mucosa (103).

Meli et al, (105) reported that endogenous bile

influences the rate of intestinal eibsorption of an estrogen (ethynylestradiol-6,7-%-3-cyclopertyl ether) in rats.

The rate of ^sorption
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of estrogen was considerably lower in biliary-cannulated rats than in
control animals.

Since the steroid is relatively water insolxible, the

presence of bile salts might have increased the solubility of the drug
in the intestinal Imen and thereby enhanced the dissolution and ab
sorption rate.

Levels of conjugated bile salts normally found in the

proximal intestine alter the permeability of everted rat intestine to
salicylate (39), salicylamide (38)* riboflavin (U3), and several other
drugs. Nightingale et al. (Il6) studied the effect of bile flow on
the absorption of s\ilfadiazine.

They showed that bile flovr is an

important factor in sulfadiazine absorption from the intestinal loops.
Feldman et al. (IjO) studied the influence of sodixim deoxycholate on
the absoiption of phenol red in the rat with different methods.

Each

of the methods provided evidence that the bile salt markedly enhanced
the absorption of phenol red by altering the permeability of the intes
tinal membranes.

Kakemi et al. (73) studied the influence of sodium

taurocholate and sodium glycocholate on the absorption of the same drug
(phenol red). They postulated that there are three likely mechanisms
by which bile salts can affect drug absorption from the rat small in
testine; first, the loss of thermodynamic activity of a drug due to the
formation of a micellar complex; second, the local concentration build
up effect, such as accumulation on the ^sorptive surface; third, the
direct effect on the permeability of the intestinal mucosa.

Kakemi et

al. (7U) also studied the influence of these bile salts on the intes
tinal absorption of sulfaguanidine. They postulated that the enhance
ment of absorption of drug was caused by the direct action of bile
salts to the structure of the absorptive s\arface.
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Some drugs like tetracycline and dextromethorphan (U2, 129)
themselves possess surface activity and infl\ience their o"wn absorption,
e.g., due to the anion's contribution to the suitTace activity in case
of dextromethorphan salts (U2).
Evidence has accumulated vrhich suggests that a drug's affinity
for the intestinal wall may be an important factor in its transport
across. In the study (71) of absorption of barbiturates a discrepancy
from the pH-partition hypothesis vxas noted.

This discrepancy was cor

related significantly with the in vitro binding to mucusal preparations
of rat small intestine.

The sorption of a sxirfactant also takes place

onto the intestinal wall and can also effect the absorption of drugs.
Nogami et al. (120) studied the sorption of ionic sm-factants (sodium
lauryl sulfate and cetyltrimethyl ammonim bromide) into the intestinal
tissue of the rats.

Kakemi et al. (68) studied the absorption of cer

tain ion-pair complexes of some pharmaceutical amines vrLth soditun
laxiryl sulfate and sodium saccharin.

It was found that the enhancement

of absorption of these drugs could better be related to the binding
behavior of these drugs to the rectal mucosal preparations.

Some

authors, in order to confimi that the binding to the mucosa is an
important factor in the absorption from small intestine, studied the
binding of fifteen drugs with mucosal homogenates.

Their experiments

indicate that the binding of drug (both ionized and un-ioniaed) to the
mucosa of the small intestine is important in absorption of drugs.
They also mentioned that while absorption from rectum is consistent
with pH-partition hypothesis, it is not so in case of small intestine.
Suzuikl et al. (163) studied the absorption of qtiinine and chlorpheni-
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ramine from the gut given with various anionic agents (including sodium
lauryl sulfate) which form ion-pair complexes.

It was found that the

increase of the drug binding to the absorptive membrane was responsible
for the enhancement of the drugs present in the form of an ion-pair
complex. The affinity of surfactants for hydrophobic surfaces and for
interfaces in general leads one to expect that they will have a pro
found influence on the behavior or condition of cell s\irfaces, which
are predominantly hydrophobic in nature.

Many cationic detergents have

a non-specific disrupting effect on the cells of bacteria and tissue,
thus precluding their systemic use. Nissim (119) studied the effect of
feeding cationic, anionic, and non-ionic surfactants on the histology
of the mouse gastrointestinal tract.

He found marked pathological

changes when the ionic surfactants were fed to mj,ce but no effects
when non-ionic s\irfactants vrere tested. However, there is evidence
that non-ionic polysorbate 80 disr\:5)ts membrane structure but there is
a rapid reconstitution of cell membrane material after treatment (80).
Triton X-100, an alkylphenyl polyether, totally disrupts lysosomes,
m3.tochondria, and erythrocyt.es (26). Taylor (l65) studied the effects
of cetyltrimethyl ammonivan bromide on transport and metabolism in the
small intestine of rat. The surfactant was found to produce no histo
logical damage to eveirted rat intestine sacs at lower concentrations
of the surfactant. But at higher concentrations, concomitant with the
mucosal damage, there was an inhibition of the transport of glucose,
methionine and water.

Nissim (ll8) had also found increased ^sorption

of glucose with various surfactants at low concentrations.

Kozlick and

Mosinger (80) had observed that low nontoxic doses of sodium lauryl
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sulfate increased the rate of absorption of glucose administered to
rabbits.

Kakemi et al. (72) also found that cationic surfactants,

cetyltrimethyl anononium bromide and benzethoniuui chloride, caused sn
increase in the absorption of sulfisoxazole from the rat rectum and
pointed out the resemblance of this work to those of Nissim and Taylor.
Aoki et al. (U) studied the effects of stirface active agents (ionic
and non-ionic) on intestinal absorption of drugs using three methods,
(a) circulation of the drug "with surfactant, (b) perfusion vrLth sur
factant solution followed by perfusion of drug solution free from
surfactant, and (c) feeding experiments of siirfactant solutions, follovred by circulation of drug solution. It was found that due to the
solubilizing action and degeneration of the surfactants on the mucus
membrane, the absorption of ionized species was decreased more compared
to its normal absorption, but the absorption of un-ionized species of
the drug was not decreased in the presence of surfactants, rather it
was increased. The other effect observed was decreased absorption of
drugs due to coirrolexation with surfactants (non-ionics had least action
in this respect).

Nadai et al. (113) found that sodium lauryl sulfate

produced pronotinced changes in the gross appearance of the mucosal
surface of the small intestine of the rat and thj.3 is invariably ac
companied by the increased changes in permeability.

Morphological

changes were associated conceivably with the solubilization of the
lipid cciT^Jonents of the membrane such as lipoproteins.

CHAPTER III
OBJECTIVES OF RESEARCH
In spite of the fact that DSS and polaxalene are used widely
in medicine as fecal softeners very few reports are available of their
effects on absorption of drags. The ptirpose of this study was to find
the effects of DSS and polaxalene on the absorption of a poorly ab
sorbed drug (phenol red) and a poorly soluble drug (s\ilfisoxazole).
Although Lish (96) has studied the effects of DSS and polaxalene on
the absorption of phenol red, his study was limited to only rat colons
and only to one concentration of the surfactants.

Since the action of

STirfactants on the absorption of drugs is known to be concentration
dependent and since phenol red, like most other dmgs, is absorbed
mainly from the upper gastrointestinal tract, a more detailed study of
the effects of DSS end polaxalene on the absorption of phenol red and
stilfisoxazole was deemed necessary.
The objectives of this study are the following:
(1) Determination of the effects of the surfactants on the
absorption of phenol red and sulfisoxazole from intact
rat,
(2) Determination of the effects of the surfactants on the
absorption of phenol red from rat small intestinal loops.
(3) Determination of the effects of DSS on the absorption of
phenol red from peritoneal cavity of the rat.

CHAPTER IV
EXPERIMENTAL
Materials
The following materials were used in these experiments:
Phenolsulfonphthalein (phenol red)
J. T. Baker, Analytical Grade
Dioctyl Sodium Sulfosuccinate (DDS)
E. H. Sargent and Conpany
Polaxalene, "Polyoxyethylene polyoxypropyline polymer"
(Pluronic F-68)
T^andote Chemicals, Vfyandote, Michigan
Sulfisoxazole (U.S.P.)
Hoffman LaRoche, New Jersey
Octanol-1 (n-Octanol)
J. T. Baker, Analytical Grade
Procedures
Influence of DSS and Polaxalene on
the Gastrointestinal Absorpti^
of Phenol Red
Intestinal loop.

Male Sprague Dawley rats, weighing between

195 and 330 grams, were starved for 18-20 hours with water allowed ad
libitum.

The rats were anesthetized with ether and a midline incision
51
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OH
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/N
SC\NHCHi
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Cp-Ht
CH2.C00CH5>,-CH CCHX} 3 C H 3
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Drug Fonmilas
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was made to expose the abdominal cavity.

A small incision was made in

the small intestine about 0.5-1 cm from the pyloric end and a hypo
dermic needle (22 gauge) with a blunt end was inserted into the inci
sion and secured tightly with a silk suture.

Another small incision

was made in the small intestine about 0.5-1 cm from the ileo-cecal
junction and this portion of the small intestine was kept outside the
abdominal cavity.

About 3 ml of normal saline was placed in the peri

toneal cavity to hydrate the intestine. Nomal saline (50 ml) was
pushed slowly through the small intestine \jntil the washings became
clear of the particulate matter.

The rats were kept under anesthesia

for 20-25 minutes, before closing the ileo-cecal end, to allow for
absorption of any residual liq\aid.
Exactly 5 ml of phenol red solution (0.75 mg/ml) in distilled
water or in various concentrations of the surfactant solution was in
jected into the intestinal loop from the pyloric end.

The needle was

then taken out, making sure that no solution came out and the suture
was tightly secured at the same time.

The abdominal cavity was closed

with sutTires and the animal was left for 3 hoiu's. During this time
the animal had recovered from anesthesia and was kept in a cage.

The

animal was sacrificed after the 3-hour period; the whole small intes
tine was removed and washed with normal saline to get rid of any blood
on its surface.

Then it was homogenized in a Waring blender with a

little water (96) and transferred to a 500 ml volumetric flask. To
this was added the calculated volume of 9$% ethanol needed to make the
final solution 10% in ethanol content.

The blender was rinsed with

distilled water and the washings were added to the volximetric flask

Sh

and then the voltune was made up to 500 ml with distilled water.

The

solution was left for 30 minutes to allow for precipitation of pro
teins.

Then about 3^ nil of this solution was centrifuged at 7,000

r.p.m. for 20 minutes. Then 25 ml of the clear supernatant solution
was pippetted out and transferred to a ^0 ml volumetrtc flask.

Then

1 ml of 2N NaOH was added and the volume was made up to 50 ml with 70%
ethanol.
The absoi^ance of this solution was measured at 560 m>i against
70% ethanol in a Bausch & Lomb Spectronic 600 spectrophotometer.
The percent of phenol red absorbed was calculated by measroring
the difference in absorbancy between the original solution diluted in
the same manner (5 ml to 1,000 ml) and the intestinal homogenate
solution.
This method for calculating the percent absorption of phenol
red runs a higher risk of experimental error compared to a direct
measurement. However, extreme care was taken in introducing the same
volume of drug solution into the intestinal loop each time. Furthermore,
the study deals with the differences between phenol red solution and
phenol red solutions containing surfactants, so that any experimental
error due to the techniques was expected to be constant.
Gastric intubation.

Male Sprague Dawley rats -weighing between

195 and 300 grams were starved for 18-20 hours, with water allowed ad
libit\3m.

The experiments were performed in a cross over fashion, i.e.,

each rat serving as its own control.
Each rat received a control dose of 2 ml of phenol red solution
in distilled water (0.75 mg/ml) by gasti*ic intubation (by means of a
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Tygon tube). The animal was then kept in a metabolic cage, and water
was allowed ad libitum, but food was withheld.

The urine was collected

for a period of 2h ho\irs.
After a recovery period of three days, the same rat received
2 ml of phenol red solution (0.75 mg/ml) in one of the different con
centrations of the surfactants studied.

The urine was collected for a

period of 2h hours as mentioned before.
Half the number of animals first received control doses of the
drug, followed by a dose of the dr\ig with the surfactant after the re
covery period.

While in the other half nioniber of animals, the procedure

was reversed, i.e., first a dose of the drtig was given with the surfac
tant followed by a control dose of the drug after the recovery period.
The pH of the urine was adjusted to 10.00 vjith 2N sodium
hydroxide solution and the volume of the sanple was made up to 50 ml.
A portion of the sanple was filtered through Millipore filter (O.U5
and its phenol red content was determined by measuring its absorbance
against a blank prepared in the same manner as the sample, at 560 mja
in a spectrophotometer (38)*
Using a standard curve for phenol red, the percent of the dose
absorbed by the rat was calculated.
Influence of DSS on the PeirLtoneal
Absorption of Phenol Red
Male Sprague Dawley rats weighing between 210 and 380 grams
were starved for 18-20 hours with water allowed ad libitum.

The exper

iments were performed in a cross over fashion, i.e., each rat serving
as its own control.
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Each rat received a control dose of 0.5 ml of phenol red solu
tion in distilled water (0.75 mg/ml) by intraperitoneal injection. The
animal was kept in a met^olic cage, and water was allowed ad libitum
but food was withheld.
hours.

The tirine was collected for a period of 2U

After a recovery period of three days the same rat received a

dose of 0.5 ml of phenol red solution (0.75 mg/ml) in one of the dif
ferent concentrations of DSS in distilled water. The urine was again
collected for a period of 2h hours as mentioned before.
The content of phenol red in the urine was determined as
described previously mder "Gastric intubation", but the voliime of
urine was made up to 100 ml.
Effect of DSS and Polaxalene on the
Equilibritun Solubility of "Phenol
Red at 37^0.
Excess amounts of phenol red powder were placed in 25 ml anpules
and then 10 ml of various solutions of the STirfactants were added to
the an5)ules.

The arapxiles were sealed and rotated in a Metabolyte shaker

maintained at 37®C.

After equilibrium was achieved (approximately 3

days), an aliquot was filtered through a Millipore filter (O.U5 >i).
One ml of this filtered solution was diluted to 500 ml after adding
2N sodixim hydroxide to adjust pH to 10.0. The absorbance of this solu
tion was measured at 560 mu in a spectrophotometer.
Effect of DSS on the Apparent Partition
Coefficient of Phenol Red betvreen
Octanol-1 and Surfactant Solution
Solutions of phenol red (0.05^) were prepared in phosphate
buffer^ (M/IOO and pH 6.0) or in the same biiffer containing various
Iciark and Lubs Phosphate Buffer.
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concentrations of DSS. Ten ml of buffered phenol red solution was
added to an equal volume of octanol-1, previously saturated with the
buffer solution, in a ^0 ml Erlenmeyer flask.
ibrated at 37°C for two days.

The contents were equil

After separation by centrifugation (at

11,000 r.p.m., for 30 minutes, and at 37°C) an aliquot (l ml) of the
aqueous phase was rendered alkaline (pH 10.0) with sodium hydroxide
solution and diluted to 2^0 ml with distilled water.
of this solution was measured at 560

The absorbancy

and the apparent partition

coefficient was calculated from the decrease JLn the concentration of
phenol red in the aqueous phase.
Influence of DSS on the Gastrointestinal
Absorption of Sulfisoxazole
Gastric intubation.

Male Sprague Dawley rats weighing between

200 and 2U0 grams were starved for 18-20 hours, with water allowed ad
libitum.

The experiments were performed in a cross over fashion, i.e.,

each rat serving as its own control.
Each rat received a control dose of 5 mg of sulfisoxazole in
the form of a suspension in distilled water. Preparation of a drug
suspension was done in situ by placing the drug into the barrel of a
dry 5 ml syiringe, adding 2 ml water to it and intubating the resulting
suspension.

An additional 1.5 ml of water was added in small increments

to ensure conplete delivery of the drug from the syringe. The animal
was then kept in a metabolic cage, water was allowed ad libitum but
food was withheld.

The urine was collected for a period of 2U hours.

After a recovery period of three days the same rat received
the same amount of the dmg suspended in 2 ml of one of the various
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concentrations of the DSS solution.

A 1.^ ml of water was added in

small increments to the syringe to ensure complete delivery of the
drug. The urine was collected for a period of 2h hours as mentioned
before.
Half the number of animals first received control dose followed
"by a dose of the drug with the surfactant after the recovery period.
I-Jhile in the other half nrmiber of animals, the procedvire was reversed,
i.e., first a dose of the drug was given with the surfactant, followed
by a control dose of the drtig after the recovery period.
UirLnary analysis for sulfisoxazole. The total urinary excre
tion of the sulfisoxazole (free, as well as acetylated portion) by the
modified Bratton and Marshal method (30).
Urine was diluted to exactly 100 ml and a 10 ml aliquot was
pippetted out in a 100 ml volumetric flask, to which was added 10 ml
of 0.^ N hydrochloric acid. This mixture was heated on a steam bath
for one hour to hydrolyze the acetyl ated portion of the excreted drug.
After cooling, 10 ml of a 0.1^ solution of sodlTom nitrite, freshly pre
pared, was added and shaken thoroughly.

After 6 minutes, 10 ml of a

0.5^ solution of ammonium sulfamate was added and shaken thoroughly.
The pH of the resulting solution was checked and adjusted to a value
of approximately 1.3-l.U with 1 N hydrochloric acid.

Six minutes

after the addition of ammonium sulfamate, 10 ml of a 0.1^ solution of
N-l-Naphthylethylenediamine dihydrochloride was added.

The voltune was

adjusted to 100 ml and a portion of it was filtered through a KLllipore
filter (O.li^ u).

The absorbance of this solution was read at 533

against a blank prepared in the same manner.

^9
The amount of sulfisoxazole absorbed was calcxilated by means
of a standard cujrve.
Effect of DSS on the Solubility of
Sulfisoxazole at Room Temperature
Sulfisoxazole (lOO mg) was placed in a 20 ml test tube and
5 ml of various concentrations of DSS solutions, prepared in M/5
phosphate buffer, were added to it.

The tube was shaken at a medium

speed on a vortex mixer for exactly 5 minutes at room temperature.
was then filtered through a Millipore filter (o.U5 >i).

It

One ml of this

filtered solution was properly diluted with a phosphate buffer of pH
7.5

Absorbance of this solution was read against a blank

(phosphate buffer) at 2^2 mji.
Statistical Analysis of Res\alts
To find out the significance of the effect of various concen
trations of surfactants a student t test for the significant difference
in the means was performed.

An analysis of variance in conjunction

with an F test was also performed. This analysis involves an extension
of the pooled variance technique and the calctilation of a variance
ratio.

This is in contrast to the ratio of the difference between

means to the standard error of the difference required by the t test.
This analysis answers the same question as a student t test does for
the difference between two means and is used as a test of significance
for two or more groups of data.
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Table 1
Influence of DSS on the Gastrointestinal Absorption
of Phenol Red - Intestinal Loop
Phenol Red

Absort>ance at $60 irqa
Percent Dose
Absorbed
Rat

Phenol Red
Solution

1

0.668

0.6U0

U.19

2

0.668

0.635

U.9U

3

0.563

0.5U0

U.08

h

0.563

0.5U0

U.08

0.563

0.537

U.62

0.573

0.5U5

U.89

0.5996

0.5728

U.U667

Standard
Devi ation

0.0502

0.U006

Standard
Error

0.0205

0.1635

6

Arithmetic
Mean

Intestinal
Homogen ate
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Table 2
Influence of DSS on the Gastrointestinal Absorption
of Phenol Red - Intestinal Loop
Phenol Red + 0,2^% DSS (12.5 nig)

Absorbance at 560 it^i
Percent Dose
Absorbed
Rat

Phenol Red
Solution

Intestinal
Homogenste

1

0.595

0.505

6.72

2

0.595

0Ji70

21.00

3

0.595

0.500

16.00

U

0.595

0.h75

20.17

5

0.595

0.U60

22.67

6

0.595

O.U85

18.50

Arithmetic Ke an

0.U825

17.5100

Standard Deviation

0.0175

5.75UU

Standard Error

0.0071

2.3500

t = 5.5387 (significant difference at p < .001 when compared to control)
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Table 3
Influence of DSS on the Gastrointestinc*! Absorption
of Phenol Red - Intestinal Loop
Phenol Red +

DSS (2^ mg)

Absorbance at 560 mvi
Percent Dose
Absorbed
Rat

Pheno]. Red
Solution

1

0.^90

0.390

33.88

2

0.^90

0.380

35.59

3

0.590

0.360

38,98

U

0.590

O.3I4O

)p. ^7

5

0.590

0.185

68.6U

6

0.590

0.160

72.68

7

0.590

0.130

77.96

6

0.590

0.120

79.66

9

0.590

0.380

35.59

Arithmetic Mean

0.2717

53.9278

Standard Devi ation

0.1188

20.1223

Standard Error

0.0396

6.707U

Intestinal
Homogen ate

t = 5.9UUU (significant difference at p< .001 when copqjared to control)
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Tdjle U

Influence of DSS on the Gastrointestinal Absoiption
of Phenol Red - Intestinal Loop
Phenol Red + 1.0^ DSS (50.0 mg)

Absorbance at 560 npa
Percent Dose
Absorbed

Rat

Phenol Red
Solution

Intestinal
Homogen ate

1

0.600

0.353

U1.177

2

0.600

O.IUO

76.67

3

0.600

O.lhO

76.67

li

0.600

0.115

80.83

0.600

0.108

82.00

0.600

0.095

8ii.l7

Arithmetic Mean

0.1^8^

73.58U5

Standard Deviation

0.0969

16.157U

Standard Error

0.0396

6,6000

6

t = 10.U76 (significant difference at p <.001 when compared to control)

6h

Table ^
Influence of I)SS on "the Gastrointestinal Absorption
of Phenol Fed - Intestinal Loop
Phenol Red + 1,^% DSS (7^.0 mg)

Absorb ance at 560 m|i
Percent Dose
Absorbed

Rat
Phenol Red
Solution

Intestinal
Homogen ate

1

0.^90

0.380

35.59

2

0.590

0.3U0

U2.37

3

0.590

0.305

U8.3O

U

0.590

0.265

55.08

0.590

0.270

5U.2U

0.590

0.185

68.6U

Arithmetic Mean

0.2908

50.7033

Standard Deviation

0.0676

II.I1632

Standard Eri*or

0.0276

U.6807

6

t = 9.8739 (significant difference at p < .001 when compared to control)
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Table 6
Influence of DSS on the Gastrointestinal Absorption
of Phenol Red
Total Urinary Excretion of Phenol Red in Individual
Rats after Gastric Intubation of Phenol Red (1.5 mg
dose) with and -without 0.5^ DSS (10 mg).

Control

DSS

Rat

Absorbance
at 560 m^

Percent Dose
Absorbed

Absorbance
at 560 in)i

1

0.260

5.U2O

0.365

7.609

2

0.290

6.0U5

o.iao

8.5U7

3

0.210

U.378

0.350

7.296

h

0.280

5.837

0.U70

9.798

5

0.216

U.503

0.360

7.505

6

0.220

U.586

0.382

7.963

7

0.230

U.795

O.UOO

8.338

8

0.190

3.961

O.U3O

8.96U

9

0.200

U.169

O.U65

9.693

Arithmetic
Mean

0.2329

U.85U8

0.U036

8.U125

Standard
Deviation

0.0356

0.7U13

0.0UU2

0.9223

Standard
Error

0.0118

0.2U71

0.01U7

0.307U

t = 9.6IU7 (significant difference at p < .001)

Percent Dose
Absorbed
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T^le 7

Influence of DSS on the Gastrointestinal Absorption
of Phenol Red
Total Urinary Excretion of Phenol Red in Individual
Rats after Gastric Intubation of Phenol Red (1.5 mg
dose) with and vdthout 1.0^ DSS (20 mg).

Control

Rat

Absorb ance
at 560 in)i

DSS

Percent Dose
Absorbed

Absorb ance
at 560

PercentDose
Absorbed

1

O.3UO

7.088

O.U8O

10.006

2

0.210

U.378

0.310

6.U62

3

0.270

5.628

O.UlU

8.630

u

0.310

6.U62

0.530

11.0U9

0.212

U.U19

0.580

12.091

6

0.217

U.52U

0.580

12.091

7

0.300

6.25U

O.7UO

15.U26

8

0.261

5.uia

O.7UO

I5.U26

9

0.210

U.378

0.U3U

9.0U7

Arithmetic
Mean

0.2589

5.3969

0.53U2

II.I36U

Standard
Deviation

0.0U97

1.0355

o.iua3

3.0085

Standard
Error

0.0165

0.3U52

O.OU8I

1.0028

t = 5.8987 (significant difference at p < .001)
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Table 8
Influence of DSS on the Gastrointestinal Absorption
of Phenol Red
Total Ui*inary Excretion of Phenol Red in Individual
Rats after Gastric Intubation of Phenol Red (1.5 mg
dose) with and without 1.5^ DSS (30 mg).

Control

DSS

Rat

Absorb ance
at 560 inji

Percent Dose
Absorbed

Absorbance
at 560

1

0.230

U.795

0.388

8.088

2

0.2UU

5.086

0.500

10.U23

3

0.238

li.96l

O.U95

10.319

h

0.2U7

5.1U9

0.558

11.632

5

0.20h

U.253

0.ii80

10.006

6

0.220

U.586

0.605

12.612

7

0.190

3.961

0.500

IO.U23

8

0.190

3.961

0.565

11.778

9

0.190

3.961

0.690

lii.38U

Arithmetic
Mean

0.2170

U.5237

0.^312

11.0739

Standard
De^rLation

0.02U0

0.h999

0.0858

1.7889

Standard
Error

0.0079

0.1666

0.0186

0.5963

t = 9.68^9 (significant difference at p <.001)

Percent Dose
Absorbed

68
Table 9
Influence of DSS on the Gastrointestinal Absorption
of Phenol Red
Total Urinary Excretion of Phenol Red in Individual
Rats after Gastric Intubation of Phenol Red (l.^ mg
dose) with and without 2»0% DSS (UO mg).

Control

DSS

Rat

Absorbance
at 560 mji

Percent Dose
Absorbed

Absorbance
at 560

1

0.2U5

5.107

0.351

7.317

2

0.215

U.U82

0.385

8.026

3

0.195

U.065

0.365

7.609

U

0.165

3.UU0

0.325

6.775

0.190

3.961

0.362

7.5U6

6

0.195

U.065

o.Uoo

8.338

7

0.135

2.81U

0.300

6.251;

8

0.210

U.378

0.U90

10.215

9

0.2U0

5.003

0.560

11.673

Arithmetic
Mean

0.1978

U.IU6I

0.3931

8.19U8

Standard
Deviation

0.0350

0.7198

0.0823

1.7156

Standard
Error

0.0115

0.2399

O.O27U

O.57I8

t = 8.8382 (significant difference at p < .001)

Percent Dose
Absorbed
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Table 10
Influence of DSS on the Peritoneal Absorption
of Phenol Red
Total Urinary Excretion of Phenol Red in Individual Rats
after Intraperitoneal Administration of 0.37^ mg dose of
Phenol Red with and without 0.01^ DSS (O.O^ mg).

Control
Rat

Absorbance
at 560

DSS

Percent Dose
Absorbed

Absorbance
at 560 rrgi

Percent Dose
Absorbed

1

O.3UO

$6,102

o.iao

68.376

2

0.315

53.533

0.380

63.373

3

O.U05

67.5U2

O.U35

72.5U5

U

0.3U5

57.536

O.UI5

69.210

5

O.U05

67.5U2

0.U22

70.377

Arithmetic
Mean

0.3620

60.3711

0.U12U

68.7763

Standard
Deviation

0.0U09

6.8152

0.020U

3.U026

Standard
Error

0.0182

3.0U79

0.0091

1.5217

t = U.U96O (significant difference at p ^ .02)
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TdDle 11
Inriuence of DSS on the Peritoneal Absorption
of Phenol Red
Total Urinary Excretion of Phenol Red in Individual Rats
after Intr^eirLtoneal Administration of 0.37^ mg dose of
Phenol Red with and without 0.0^/S DSS (0.2^ ing).

Control

DSS

Rat

Absorbance
at 560 rnji

Percent Dose
Absorbed

Absorbance
at 560 iT^

1

0.332

55.368

0.390

65.Ola

2

O.2i1o

U0.025

0.320

53.367

3

0.320

53.367

0.370

61.705

U

0.3^5

59.20U

0.385

6u.207

0.30^

50.8651

0.360

60.037

Arithmetic
Mean

O.3IOU

51.7657

0.365

6o.87iu

Standard
Deviation

0.0U3U

7.2373

0.0278

U.6U27

Standard
Error

0.019U

3*236?

0.012U.

2.0763

t = 6.816U (significant difference at p < .00^)

Percent Dose
Absorbed
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T^le 12
Influence of DSS on the Peritoneal Absorption
of Phenol Red
Total Urinary Excretion of Phenol Red in Individual Rats
after Intrsperitoneal Administration of 0.37> mg dose of
Phenol Red with and without 0.10^ DSS (0.50 mg).

Control

DSS

Rat

Absorbance
at ^60 iryi

Percent Dose
Absorbed

Absorb ance
at 560 m)i

Percent Dose
Absorbed

1

0.310

51.699

0.350

53.370

2

0.29^

U9.197

0.320

53.367

3

0.325

5U.200

0.358

59.70U

U

0.260

U3.360

0.310

51.699

0.320

53.366

0.330

55.O3U

Arithmetic
Mean

0.3020

50.36u8

0.3336

55.63U8

Standard
Deviation

0.0261

U.3569

0.0201

3.355U

Standard
Error

0.0117

1.9U85

0.0090

1.5006

t = U.6^60 (significant difference at p <.01)
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Table 13
Influence of DSS on the Peritoneal Absorption
of Phenol Red
Total Urinary Excretion of Phenol Red in Individual Rats
after Intrsperitoneal Administration of 0.375 ng dose of
Phenol Red with and without 0.50^ DSS (2.50 mg).

Control
Rat

Absorbance
at 560 mji

DSS

Percent Dose
Absorbed

Absorb ance
at 560 npi

Percent Dose
Absorbed

1

0.300

50.031

0.250

Ul.693

2

0.280

U6.696

0.237

39.525

3

0.2U3

U0.525

0.165

27.517

U

0.290

u8.36u

O.2I43

UO.525

5

0.355

59.2037

0.310

51.699

Arithmetic
Mean

0.2936

u8.9639

o.2mo

UO.i9i8

Standard
Deviation

0.0U05

6.758U

0.0516

8.6oou

Standard
Error

0.0181

3.0225

0.0231

3.8u63

t = 8.1u9u (significant difference at p < .005)
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Table lU
Influence of DSS on the Peritoneal Absorption
of Phenol Red
Total Urinary Excretion of Phenol Red in Individual Rats
after Intr^eritoneal Administration of 0.37^ mg dose of
Phenol Red with and without 1.00^ DSS (5.00 mg).

Control

DSS

Rat

Absorbance
at 560 11^

Percent Dose
Absorbed

Absorb ance
at 560 rrgi

Percent Dose
Absorbed

1

0.370

61,705

0.210

35.022

2

0.310

51.699

0.200

33.35U

3

0.320

53.367

0.175

29.185

h

0.320

53.367

0.195

32.520

0.360

60.037

0.280

U6.695

Arithmetic
Mean

0.3360

56.0350

0.2120

35.355U

Standard
Deviation

0.0272

U.5058

O.OUOl

6.6865

Standard
Error

0.0122

2.0151

0.0179

2.990U

t = 8.9im (significant difference at p < .001)

7h

Table 15
]jifl-uence of DSS on the Peritoneal Absorption
of Phenol Red
Total Urinary Excretion of Phenol Red in Individual Rats
after Intraperitoneal Adinini strati on of 0.3715 mg dose of
Phenol Red with and without 1.^0^ DSS (7.5 nig).

Control

DSS

Absorb ance
at 560 mji

Percent Dose
Absorbed

Absorb ance
at 560

Percent Dose
Absorbed

1

0.293

U8.86U

0.12U

20.680

2

0.350

58.370

0.160

26.683

3

0.3U0

56.702

0.170

28.351

U

0.367

61.205

0.218

36.356

5

0.360

60.037

0.200

33.35U

Arithmetic
Mean

0.3U20

57.0356

0.17UU

29.08U8

Standard
Deviation

0.0292

U.8750

0.0365

6.0838

Standard
Error

0.0130

2.1802

0.0163

2.7208

t " 2U,8031 (significant difference at p

A
•
o
o
H

Rat

75
Table l6
Influence of Polaxalene on the Gasti\5intestinal Absorption
of Phenol Red - Intestinal Loops
Phenol Red

Absorbance at 560
Rat

Phenol Red
Solution

Intestinal
Homogenate

Percent Dose
Absorbed

1

0.668

0.6U0

U.19

2

0.668

0.635

U.9U

3

0.563

0.5U0

U.08

h

0.563

0.5U0

U.08

5

0.563

0.537

U.62

6

0.573

0.5U5

U.89

0.5996

0.5728

U.u667

Standard
Devi ation

0.0502

0.)4006

Standard
Error

0.0205

0.1635

Arithmetic
Mean

I
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Table 1?
Influence of Polaxalene on the Gastrointestinal Absorption
of Phenol Red - Intestinal Loops
Phenol Red + \% Polaxalene (^0 mg)

Absorbance at 560 mji
Rat

Phenol Red
Solution

Intestinal
Homogenate

Percent Dose
Absorbed

1

0.^75

0.5U7

U.87

2

0.57^

0.555

3.U8

3

0.^7^

0.560

2.68

U

0.57^

0.552

U.OO

5

0.575

0.550

U.35

6

0.575

0.551

U.17

Arithmetic Mean

0.5525

3.9250

Standard Deviation

0.00U5

0.7599

Standard Error

0.0018

0.3102

t « 1.5UU5 (no significant difference when coirpared to control)
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Table 18
Influence of Polaxalene on the Gastrointestinal Absorption
of Phenol Red - Intestinal Loops
Phenol Red + 2% Polaxalene (100 mg)

Absorbance at 560 up
Rat

Phenol Pied
Solution

Intestinal
Homogenate

Percent Dose
Absorbed

1

0.570

0.5U0

5.26

2

0.570

0.5U0

5.26

3

0.570

0.550

3.51

\x

0.570

0.5Li7

U.03

$

0.570

0.550

3.51

6

0.570

0.555

2.70

Arithmetic Mean

0.5U7

U.0U5

Standard Deviation

0.006

1.0329

Standard Error

0.002U

0.U217

t = 0.9323 (no significant difference when conpared to contixjl)
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Table 19
Influence of Polaxalene on the Gastrointestinal Absorption
of Phenol Red - Intestinal Loops
Phenol Red + 3^ Polaxalene (l^O mg)

Absorbance at 560 mji
Percent Dose
Absorbed

Rat

Phenol Red
Solution

Intestinal
Homo gen ate

1

0.^90

0.580

1.69

2

0.590

0.580

1.69

3

0.^90

0.580

1.69

h

0.590

0.585

0.85

5

0.590

0.585

0.85

6

0.590

0.575

3.36

Arithmetic Mean

0.5808

1.U3U8

Standard Deviation

0.0038

1.1066

Standard Error

0.0015

O.U518

t = 6.8038 (significant difference at p <.001 when compared to control)
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Table 20
Influence of Polaxalene on the Gastrointestinal Absorption
of Phenol Red - Intestinal Loops
Phenol Red +

Polaxalene (2^0 mg)

Absorbance at 560 nyi
Percent Dose
Absorbed

Rat

Phenol Red
Solution

Intestinal
Homo gen ate

1

0.^90

0.585

0.85

2

0.^90

0.585

0.85

3

0.^90

0.585

0.85

U

0.590

0.570

3.39

0.^90

0.565

U.2)4

0.590

O.U65

U.2U

Arithmetic Mean

0.5758

2.U023

Standard Deviation

0.0102

1.728U

Standard Error

0.00U2

0.7057

6

t = 2.8U66 (significant difference at p <.01 when compared to control)
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Table 21
Influence of Polaxalene on the Gastrointestinal Absorption
of Phenol Red
Total Urinary Excretion of Phenol Red in Individual Rats
after Gastric Intubation of Phenol Red (l.^ itig dose) with
and without 0.^% Polaxalene (10 mg).

Control

Polaxalene

Rat

Absorbance
at $60 ngi

1

O.lUO

2.918

0.250

5.212

2

0.295

6.150

0.330

6.879

3

0.260

5.U20

0.200

U.169

U

0.320

6.671

0.220

U.586

5

0.3U0

7.088

0.3U0

7.088

Arithmetic
Mean

0.2710

5.6U9U

0.2680

5.5868

Standard
Deviation

0.0791

1.6U87

0.0638

1.3299

Standard
Error

0.035U

0.7373

0.0285

0.59U8

Percent Dose
Absorbed

t = 0.0818 (no significant difference)

Absorb ance
at 560 rr^i

Percent Dose
Absorbed

ei
Table 22
Influence of Polaxalene on the Gastrointestinal Absorption
of Phenol Red
Total Urinary Excretion of Phenol Red in Individual Rats
after Gastric Intubation of Phenol Red (1.5 mg dose)
with and without 1,^% Polaxalene (30 mg).

Control
Rat

Absorb ance
at 560 Tn)i

Polaxalene

Percent Dose
Absorbed

Absorb ance
at 560 rnji

Percent Dose
Absorbed

1

0.220

U.586

0.200

u.i69

2

0.260

5.U20

0.160

3.335

3

0.2U0

5.003

0.2U0

5.003

U

o.iuo

2.918

0.200

a.169

0.22U

U.670

0.270

5.628

6

0.170

3.5hU

0.180

3.752

7

0.2^6

5.337

0.200

u.i69

Arithmetic
Mean

0.2157

U.U968

0.2071

U.3I82

Standard
Devi ation

0.UU9

0.9355

0.0368

0.7680

Standard
Error

0.0170

0.3536

0.0139

0.2903

t = o.uou? (no significant difference)
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Table 23
Influence of Polaxalene on the Gastrointestinal Absorption
of Phenol Red
Total Urinary Excretion of Phenol Red in Individual Rats
after Gastric ]jnitubation of Phenol Red (1.5 mg dose)
with and without 2.^% Polaxalene (50 mg).

Control

Polaxalene

Rat

Absorbance
at 560

Percent Dose
Absorbed

1

0.260

5.U20

0.220

U.586

2

0.170

3.5UU

0.280

5.837

3

0.310

6.U62

0.250

5.212

U

0.310

6.U62

0.220

U.586

5

0.280

5.837

0.270

5.628

6

0.200

U.169

0.286

5.962

Arithmetic
Mean

0.2^^0

5.3159

0.25U3

5.3015

Standard
Devi ation

0.0582

1.2138

0.0293

0.6097

Standard
Error

0.220

O.U588

0.0111

0.230u

t = 0.0201 (no significant difference)

Absorb ance
at 560 rga

Percent Dose
Absorbed
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Table 2h
Influence of Polaxalene on the Gastrointestinal Absorption
of Phenol Red
Total Urinary Excretion of Phenol Red in Individual Rats
after Gastric Intubation of Phenol Red (1.^ mg dose)
with and without ^,0% Polaxalene (100 mg).

Control

Polaxalene

Rat

Absorbance
at 560 Tn}i

Percent Dose
Absorbed

Absorbance
at $6o nqi

1

0.280

5.837

0.170

3.51^11

2

0.260

5.U20

0.230

U.795

3

0.180

3.752

0.100

2.085

U

0.190

3.961

0.200

U.169

5

0.290

6.0li5

0.180

3.752

Arithmetic
Mean

O.2uoo

5.0031

O.i76o

3-6690

Standard
Deviation

0.0^1^

1.0731

O.ou83

I.oo63

Standard
Error

0.0230

O.U799

0.0216

O.U^OO

t « 2.71h2 (significant difference at p < .05)

Percent Dose
Absorbed

eu
Table 2$
Effect of DSS on the Apparent Partition Coefficient of
Phenol Red between Octanol-1 and S\irfactant Solution

Concentration
of DSS ^

Absorbance of Aqueous Phase
at 560 mu
Af+.F>T*
Partitioning^ Partitioning^

Apparent Partition
Coefficient
Octanol—1/DSS Solution

0.

0.325

0.297

0.086

0.01

0.319

O.29I1

0.078

0.10

0.320

0.296

0.075

0.25

0.329

0.305

0.073

0.50

0.319

0.295

0.075

1.00

0.320

0.298

0.069

1.50

0.332

0.306

0.078

^Average of two sanples.
^Average of three senples.
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Table 26
Effect of Polaxalene on the Eqtiilibriuin Solubility
of Phenol Red at 37° C

Concentration of
Polaxalene (Percent)

Absorbance at

560

Solvibility of Phenol
Red (gm/litre)^

0

0.370

1.1^6

0."^

0.378

1.181

1.0

O.U37

1.366

2.0

0.UU8

i.Uoo

3.0

O.U86

1.^19

U.o

0.U9U

l.^hU

^.0

0.^00

1.563

^Average absorbancies of six samples.
^Calculated by the following equation:
Absorbancy = e x concentration (mg/litre)
e = 0.l6, as determined by the method of least squares
from the standard curve.
Factor of dilution: 1 to ^00 ml.
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Table 27
Effect of DSS on the Equilibrium Solubility
of Phenol Red at 37° C

Concentration of
DSS (Percent)

Absorbance at
560 mp®-

Solubility of Phenol
Red (gm/litre)^

0

0.370

1.156

0.25

0.U2U

1.325

0.50

0.U80

1.500

0.75

0.515

1.609

1.00

0.558

1.7UU

1.25

0.578

1.806

1.50

0.590

l.SlUi

2.00

0.639

2.166

^Average absorbancies of six samples.
^Calculated by the following equation:
Absorbance = e x concentration (mg/litre)
e = 0.16, as determined by the method of least squares
from the standard ciirve.
Factor of dilution: 1 to ^00 ml.
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Table 28
Influence of DSS on the Gastrointestinal Absorption
of Sulfisoxazole
Total Urinary Excretion of Sulfisoxazole in Individual
Rats after Gastric Intubation of Sulfisoxazole
mg)
with and without 0,1% DSS (2 mg).

Control

DSS

Rat

Absorbance
at 533 1191

Dose Absorbed

1

O.UlO

3.hl7

0.U30

3.583

2

0.k20

3.500

0.U50

3.750

3

0.360

3.000

0.382

3.183

U

0.380

3.167

o.ia5

3.U58

5

O.U15

3.U58

O.U33

3.608

6

O.U95

U.125

O.U75

3.958

7

O.UlO

3.1U7

0.U50

3.750

8

0.390

3.250

0.u20

3.500

9

0.)4U0

3.667

O.U55

3.792

10

0.U20

3.500

0.u80

U.ooo

Arithmetic
Mean

O.UlU

3.U50

O.U39

3.658

Standard
Deviation

0.036

O.30u

0.029

0.2U5

Standard
Error

0.011

0.096

0.009

0.078

Absorbance
at 533 iTi)i

t = 3.80U8 (significant difference at p < .00^)

Dose Absorbed
mg
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Table 29
Influence of DSS on the Gastrointestinal Absorption
of Sulfisoxazole
Total Urinary Excretion of Sulfisoxazole in Individual
Rats after Gastric Intubation of Stilfisoxazole (5 mg)
with and i-Tithout 0.^% DSS
mg).

Control

DSS

Rat

Absorb ance
at 533 irai

Dose Absorbed
mg

Absorbance
at 533

Dose Absorbed
mg

1

0.380

3.167

0.)475

3.958

2

o.U^o

3.750

O.U65

3.875

3

0.U85

U.0u2

0.520

a.333

U

o.U?o

3.750

0.U80

U.ooo

5

0.U90

U.083

0.560

U.667

6

0.305

3.208

0.520

U.333

7

0.U20

3.500

O.u6o

3.833

8

0.U50

3.750

0.500

U.167

9

0.395

3.292

0.510

U.250

10

o.hio

3.La7

0.520

U.333

Arithmetic
Mean

0.U31

3.596

0.501

U.175

Standard
Deviation

0.039

0.329

0.031

0.260

Standard
Error

0.012

O.lOU

0.010

0.082

t = 5.27^ (significant difference at p < .001)
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Table 30
Influence of DSS on the Gastrointestinal Absorption
of Sulfisoxazole
Total Urinary Excretion of Sulfisoxazole in Individual
Rats after Gastric Intubation of Sulfisoxazole (5 mg)
with and v/ithout 1.0^ DSS (10 mg).

Control
Rat

Absorbance
at 533 iTi)i

1

O.hUO

2

DSS

Dose Absorbed
mg

Absorbance
at $33

Dose Absorbed
mg

3.667

0.^70

U.750

0.)430

3.583

0.5U0

U.500

3

0.380

3.167

0.520

U.333

h

o.Ulo

3.1U7

0.5U0

U.500

5

0.ij30

3.583

0.570

U.750

6

0.360

3.000

0.515

U.292

7

0.U20

3.500

0.585

h.875

8

0.360

3.000

0.535

U.U58

9

0.390

3.250

0.530

U.U17

Arithmetic
Mean

o.UOp

3.380

0.5U5

U.5U2

Standard
Devi ation

0.031

0.257

0.02U

0.203

Standard
Erixsr

0.010

0.085

0.008

0.067

t = 21.7398 (significant difference at p < .001)
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Td5le 31
Effect of DSS on the Solubility of Sulfisoxazole
at Room Temperature

Concentration of
DSS (Percent)

Absorb ance
at 2^2 inji

0.00

0.196^

0.01

0.211

0.0^

0.211

0.10

0.212

^Average of three sanples.

CHAPTER V

DISCUSSION
Phenol red, the drug selected for this study, serves as a good
model to study the effects of the two medicinally used surfactants,
dioctyl sodium sulfosuccinate (DSS) and polaxalene, on the absoiption
of poorly absorbed drugs.
Phenol red is a weak acid, with a molecular weight of 35U and
a pKa of 7.9 (106).

It is used as an indicator, in acid-base titra

tions, changing its color in the pH range of 6.0 to 7.^.

Using the

Henderson-Hasselbach equation, one can calculate that the degree of
ionization of phenol red at <?c pH of 5.3 (the virtual pH at the absorp
tion site in the intestine) (6l, 1U5) is only 0.2^ percent. However,
it may generate the strong benzenesulfonic acid group by acid hydrol
ysis of the sulfalactone ring at very low pH (<2). These suggest
that the poor absorption of phenol red through small intestine can be
attributed to low lipid/water partition coefficient of the un-ionized
form, while the poor absorption through the stomach can be attributed
to the degree of ionization. This account of the poor absorpability
of phenol red was suggested by Lien (93), and was confirmed by our
results, that phenol red has very low partition coefficient (Octanoll/water) as shown in Table 25.
Intestinal perfusion studies in rats have shown that phenol
red is equally well absorbed in the proximal as well as distal regions
91
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of the small intestine (108).

In the 0.5 to 20 mg per litre concen

tration range phenol red absorption from the gastrointestinal tract of
the rat occurs by passive diffusion (81). At lower concentrations,
there is appreciable contribution by the specialized transport process,
which can be inhibited by p-aminohippuric acid (82),
Influence of DSS on the Absorption of Phenol Red
Absorption from Intestinal Loops
The intestinal loop, being a well defined section of the gastro
intestinal tract of the rat, is well stiited for the study of the absorp
tion of drugs and the influence of the surfactants on their absorption.
In this technique, the animal's blood supply remains intact and, hence,
the absorption profiles obtained are more realistic.

In addition, it

is possible to control the initial concentration of the surfactant
present within the intestinal lumen, when compared to intact rat.
The results obtained from the intestinal loops are presented in
Tables 1 to 5. The percent of phenol red dose absorbed in the control
studies was about U.^ percent. This value is in good agreement with
the value of 5.6 percent reported by Feldman et al. (bO).
The Intestinal loop experiments indicate a dose-dependent
effect of DSS on the intestinal absorption of the phenol red. The
relative rate of absorption of phenol red is plotted against surfac
tant concentration, as shoim in Figure 2.

All the concentrations of

DSS studied, ho\jever, showed a highly significant increase in the
absorption of phenol red in the presence of DSS. This significance
was determined by the student's t test for independent (\mpaired) data
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Figure 2.

Ihfluonce of DSS on the Gastrointestinal Absolution of
Phenol Red - Intestinal Loops.
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(at p < .001). For exanple, at 0.2^% concentration of DSS the percent
age of absorption increased from a control value of U.U to 17.^ percent.
Hif^her concentrations of the siirfactant increased the absorption of
phenol red even more, up to a maximum of 73.^8 percent in the presence
of 1% DSS. This represents about l6-fold increase in phenol red ab
sorption compared to control studies.

A higher concentration of DSS

(1.5^) showed a smaller increase in absorption than 1% DSS, but never
theless much more than the control.
Surfactants can modify drug absorption by one or more mechanism
or mechanisms. Briefly, they may act on the biological membrane or on
the drug.

In addition, some s\irfactants may also have some pharmaco

logical properties specific to their particular chemical structure and
not related to their surfactant properties in general.

Mare than one

of these mechanisms may be operative at the same time, the magnitude
of each being dependent on the concentration of the surfactant.

Sur

factants can thus exert a two-phase effect which is a function of
concentration. Below the critical micelle concentration (CMC), absorp
tion of dnigs may be enhanced due to better contact of the solution
with the biologic membrane.

There also may be a direct effect of the

surfactant on the permeability of the biologic membrane.

Above the

CMC, a portion of the drug molecules may become "entrapped" in the
surfactant micelles and, as such, be unavailable for absorption.

The

net effect (absorption enhancement or retardation) depends to some
degree on the relative magnitude of interaction between the drug and
the surfactant.

The absorption retarding effect usually predominates

at higher concentrations, because a larger fraction of the drug is
bound in the micelles.
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The enhancement of phenol red absorption from its solutions by
DSS could be the result of ti-ro possible mechanisms. First, a change in
the physiochemical properties of the drug due to the presence of the
sxirfactant that could lead to enhanced absorption, and second, an
alteration in the permeability of the membrane could also lead to
increased absorption.
A significant change in the ability of the drug to permeate the
intestinal membrane may result from an interaction of phenol red with
DSS to form a conplex. Such a complex coTild have an increased affinity
for the intestinal lipoidal membrane and result in enhanced drug ab
sorption. The magnitude of interaction of phenol red with DSS was
determined by solubility studies (Table 26 and Figure 7).

The results

obtained show that above the CMC of DSS [0.11^] (179), the solubility
of phenol red increases, indicating micellar complexation.

The possi

bility that such a complex has a higher partition coefficient and,
hence, results in enhanced absorption seems unlikely on the basis of
our studies of the effect of DSS on the partition coefficient of phenol
red and shown in Table 2^, Both premicellar and postmicellar concen
trations had no significant effect on the partition coefficients.
However, one must keep in mind that these in vitro studies do not
necessarily represent what is happening at the biological membrane
in vivo.
On the basis of our results (intestinal loop and soltibility
studies) it can be said tha,t the overall effect of DSS on the phenol
red absorption may represent the sum of two effects;

modification of

the perineability of the membrane, and micellar complexation of the
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drug. The results obtained from the influence of the concentration of
DSS on the phenol red absorption (Tables 1 to U) suggest that the
former effect (i.e., permeability change allowing for increased absorp
tion) predominates up to a concentration of 1^ DSS.

Above this concen

tration the micellar entrapment of the drug molecules starts to pre
dominate and cause a decrease in the absorption of the phenol red.
Several authors have found that other surfactants also show a similar
concentration dependent activity (72, 69, 91, 133).
The effect of various DSS concentrations on the absorption of
phenol red could be summarized in the following scheme, similar to the
one proposed by Levy (89).
Phenol Red-DSS >H.celles

Phenol Redx

DSS Micelles

^DSS
"""^Non-micellar Complex

i

Permeability Enhancing
Effect on the Membrane

Absorption
[More rapid absorption?]

Our results seem to indicate that DSS, an anionic sxirfactant,
is preferentially absorbed at the membranes and has conceiv^ly a
direct effect by disri^sting the highly ordered structure of the gastro
intestinal epithelium, thus changing its permeability and causing an
increase in the absorption of phenol red. Nissim (118) and Nadai (113)
have reported that similar ionic surfactants (sodium lauryl sulfate, in
particular) caused a disrT:5)tion of the gastrointestinal epithelium and
thus promoted drug absorption through them.
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Recently Dujone and Shoemaker (29) have found that combination
of D3S and oxyphenistan produced cytotoxicity in the liver cell cul
tures due to increased t:5)take of oxyphenistan by the cells. They have
also found in the same study that DSS, contrary to the previous belief,
is itself absorbed from the gastrointestinal tract of the humans and
the rats.
Based on our findings and those of others, it is our conclusion
that DSS changes the permeability of the gastrointestinal epithelim
and results in its o-wn absorption as well as in increasing the absorp
tion of other drugs, such as phenol red.
Absorption of Phenol Red
in the Intact Rat
Although the in situ intestinal loop is a useful technique for
routine exploratory investigation of adjuvants, like surfactants on
drug absorption, it has some deficiencies, e.g., the animal has been
surgically manipulated and, therefore, is not under normal physiologi
cal conditions.

The importance of many factors that may influence drug

absorption, such as gastric en^tying, intestinal motility and the
direct effect of drugs on the gastrointestinal tract, can be assessed
only by means of in vivo studies, in the intact animals. Hence, it
was of interest to consider the ^sorption of phenol red, and the
effect of the surfactants on its absorption, in the intact rat. F\irthermore, it was also of interest to determine the correlation between
absorption from in situ intestinal loop technique and absorption under
normal physiological conditions in the intact rat.
Tables 6-9 show vudnaiy recovery of phenol red expressed as
percent of dose after oral administration of 2 ml of 0.7^ mg/ml solution
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in the presence of various concentrations of DSS. The ratio of the
amount of phenol red excreted with and -without DSS is plotted against
increasing concentrations of DSS as a histogram in Figure 3.
The percent of phenol red absorbed in control animals was, on
the average, about 5 percent of the dose administered. This value is
in good agreement with the Intestinal loop experiment and the value of
3.6 percent reported by Feldman and Gibaldi (UO).

The results show

that for all surfactant concentrations eiiployed there was a significant
(p < .001) increase in the gastrointestinal absorption of phenol red as
manifested by increased urinary excretion of phenol red in 2U hours.
For example, the coadministration of 0.^^ DSS (10 mg) and phenol red
Increased urinary excretion from about 5.3 percent to 8,U percent,
about a twofold increase. Higher concentrations of DSS increased the
urinary excretion even more.

Again, a maxim\jm effect was seen to be

at 1 percent to 1.5 percent (20-30 mg) level of DSS. Higher concen
trations started to cause a lesser increase in the urinary excretion.
It is significant to note that the amount of DSS given to
intact rats varied from 10 to UO mg per rat ; or, on the average,
approximately $0 to 200 mg per kg body weight of rat. Maximum effect
was observed at a dose of about 100 mg/kg of DSS (l^ concentration).
This 100 mg per kg dose of DSS was found to be the ED^q for the fecal
hydrating effect of DSS in the rats (95).
Although there were quantitative differences, in the extent of
absorption, between the intestinal loop and intact rat experiments,
nevertheless, the concentration dependent activity of the surfactant
(DSS) in the intact rat followed more or less the same pattein as
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observed in the intestinal loop. These quantitative differences are
to be expected in view of the differences in the effective drug and
surfactant concentrations at the absorption site and due to differences
in the techniques.
The results of the intestinal loop and intact rat studies both
seem to indicate that DSS promotes the dDsorption of phenol red,
through a mechanism that involves a direct action of the surfactant on
the membrane permeability. However, in the intact rat, being a more
complex system physiologically, other possible additional mechanisms
could also play a role in promoting absorption. For example, DSS has
been found to inhibit the rate of propulsion of a dye meal through the
gastrointestinal tract of the rat, chiefly by slowing the gastric
emptying rate (9U).

Such a deify in the gastrointestinal transit rate

also could be an added factor in promoting the absorption of the drug.
Absorption of Phenol Red from
the Peritoneal Membrane
In view of our findings that DSS changes the permeability of
the gastrointestinal epithelial membrane and thus causes an increase
in the absorption of a poorly absorbstble drug, phenol red, it was of
interest to determine whether DSS will have a similar effect on differ
ent membrane (peritoneal membrane).
The results of the influence of DSS on the absorption of phenol
red from the peritoneal cavity are sho'vm in Tables 10-1^ and Figure U.
The percentage of phenol red absorbed from the peritoneal cavity in the
control studies was on the average about

percent of the amount of

the dose administered. This is approximately tenfold the absorption
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from the gastrointestinal tract.

It is knoxm that peritoneal membrane

is more permeable to drugs than gastrointestinal epitheli\im and our
results are in accord "vriLth this fact and are in close agreement with
the findings of Feldman et al. (UO), that phenol red was absorbed
about tenfold more from the peritoneal cavity compared to the absorp
tion from the gastrointestinal tract of the rat. The concomitant
administration of DSS and phenol red resulted in a significant (p <• .01)
increase in the absorption of phenol red up to 0.1% DSS.

Above this

concentration of DSS the absorption of phenol red started to decrease.
The concentration dependent activity of the surfactant quali
tatively follows the same pattern as found in dDsoiption of phenol red
from both the intestinal loop and the intact rat studies. The extent
in the increase of absorption was, however, less in the case of peri
toneal absorption, and this was to be expected because of the differ
ences in nat\are of the two membranes.
The results are in accord with the following mechanism:

first,

below the CMC, the surfactant (DSS) potentiated the dDsorption of
phenol red through direct action on the biological membranes, and
second, above the CMC the drug is entrapped in the micelle and is not
readily available for absorption, hence causes a decrease in absorption
of the phenol red.
This mechanism is basically similar to the one for the effect
of DSS on the absorption of phenol red from the intestinal loops and
in intact rats.

However, in the case of peritoneal absorption study,

smaller amount of the surfactant resulted in an increase in the absorp
tion of phenol red. These differences stem from the fact that, in
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case of gastrointestinal absorption, the surfactant can interact with
mucus and/or other conqaonents of the intestinal fluids, thus reducing
the effective concentration at the absorption site.
Influence of Polaxalene on the Absolution of Phenol Red
Intestinal Loops
The results obtained from the intestinal loops are shown in
Tables 16-20. The effect of concentration of the surfactant on the
relative rate of absorption of phenol red is plotted as a histogram in
Figure 5.
Unlike DSS, polaxalene did not cause any significant increase
in the absorption of phenol red. However, at higher concentrations the
surfactant caused a significant decrease in dssorption.

According to

our results it seems that polaxalene does not change the permeability
of the intestinal membrane and, hence, there was no increase in absorp
tion. These findings are in agreement with the findings of Lish and
Weikel (96), that 1% polaxalene did not change the ^sorption of phenol
red from rat colon. It is also in agreement with the lower toxicity
of non-ionic surfactants compared to ionic surfactants (118). Other
authors (91j 128, 182) have also sho-wn that other non-ionic s\irfactants
do not promote absorption of drug solutions from gastrointestinal tract.
Levy et al. (90) found that polysorbate 80 (a non-ionic surfactant)
had no apparent effect on the absorption of salicylate, salicylamide,
and U-aminoantipyrine from their solutions from in situ rat small
intestine.
Retardation of phenol red absorption at the higher polaxalene

loU

1.0-

0.90.8-

&

0.6-

0.5-

•h
h

0.1 •

0.0
0.0

1.0

2.0

3.0

5.0

Concentration of Polaxalene (Percent)
Figure 5.

Influence of Polaxalene on the Gastrointestinal Absorption
of Phenol Red - Intestinal Loops.

10^
concentrations is due to interaction between the sxrrfactant and drug,
or, in other words, due to entrapment of the drug in the micelles.
TdDle 27 and Figure 8 show that phenol red is solubilized by the mi
celles of the surfactant.

Since the drug in the micellar phase is

unavailable for absorption, the effective concentration of drug is
less than the apparent concentration of drug; therefore, a decrease in
absorption is observed. Many authors (72, 89, 91, 133) have found that
higher concentrations of non-ionic surfactants do decrease drug absorp
tion.
Gastric Intubation
The influence of polaxalene on the absorption of phenol red
from the intact rat

is shorn in Tables 21-2U. The concentration de

pendent activity of the surfactant is sho^^m in Figure 6. The ratio of
the amount of phenol red excreted in the urine with and without pol
axalene is plotted against increasing amounts of polaxalene.
The results are similar to those obtained in the study of
intestinal loops where no increase in absorption was noticed at lower
concentrations of the surfactant, while at higher concentrations there
was a decrease in absorption. The decrease in absorption of phenol
red at higher concentrations is due to the entrapment of the drug in
the micelles of the s\irfactant.
Influence of DSS on Sulfisoxazole Absorption
Sulfisoxazole (U.S.P.) is a weak acid, with a pKa of U.62 and
is a poorly soluble dnig.
infections.

It is used in human beings for urinary tract

It is available both as tablets and suspensions.

Although
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sulfisoxazole is well absorbed from solutions, its absorption from the
solid dosage forms is dissolution rate limited and the U.S.P. now re
quires a test of dissolution for the tablets as an indication for its
biologic availability. It was of interest to find out if DSS has any
effect on its gastrointestinal absorption and the information obtained
could be valuable for the proper formulation of both tablets and stispensions of this drug.
Results of absorption studies for the intact rat are presented
in Tdales 28-30. In control rats about 70 percent of the dose admin
istered is absorbed in 2h hours.

The concomitant administration of

various concentrations of DSS in the same suspension of the drug sig
nificantly increased absorption.
VThen a drug is administered orally in solid form, the rate of
absorption is controlled by the slowest step in the following sequence:
Solid drug

dissolution
absorption
^ Drug in Solution
> Absorbed drug

In many instances the slowest or rate limiting step is found to be the
dissolution of the drug at the atosoiption site.

Since dissolution

step is the rate limiting step, therefore any factor influencing the
dissolution rate will influence its absorption. The mechanisms by
which surfactants increase the dissolution rate of a relatively waterinsoluble drug are by decreasing the interfacial tension between the
dnig and the dissolution medixam and/or by means of micellar solubiliza
tion.
To obtain an indication of the ability of DSS to solubilize
sulfisoxazole, the solubility study was performed and the results are
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shovn in Table 31 and Figure 9. It was found that the premicellar
concentrations of dss slightly increased the solubility (about 8%) of
sxilfi sox azole.
The fact thsit the solubility of sulfisoxazole was only in
creased about 8 percent, while its absorption from the gastrointestinal
tract increased by about 30 percent in the presence of DSS leads us to
believe that the enhancement of absorption is due to the sum of the
following two effects;

(a) the surfactants increase the effective sur

face area of the drug through a wetting effect and result in enhance
ment of dissolution and absorption, and (b) a direct effect on the
permeability of the membranes resulting in an increased absorption of
the drug.

Other authors (8, h3, ^2, 97, 127, l66) have also found

surfactants to increase the absorption of poorly soluble drugs by the
same mechanisms.
Biopharmaceutical Ingjlications of the Study
DSS was found to increase the absorption of phenol red, a
poorly absorbable drug.

Our results indicate that the presence of DSS

with another poorly absorbable drug, oxyphenistan, could have been the
reason for the latter's hepatotoxicity. The combination of DSS in the
same dosage form with other drugs not intended for absorption should
be carefully reconsidered.
Unlike DSS, polaxalene, which is another medicinally used sur
factant, did not increase drug absorption.

Therefore, when a fecal-

softener is formulated with other laxatives, not intended for absorption,
polaxalene represents a better choice than DSS.

CHAPTER VI
SUMI^A-HT
A poorly absorbable drug, phenol red, and a poorly watersoluble drug, sxilfisoxazole, were selected to study the effects of the
two medicinally used surfactants, dioctyl sodium s\ilfosuccinate and
polaxalene, on the absoi^ition of former drugs.
Two techniques, the in situ intestinal loop and gastric intuba
tion of intact rat, were utilised to study this effect.

The solubility

method of analysis was employed to detect micellar complexation. The .
partition coefficients (Octanol-l/water) of phenol red in the absence
and presence of various concentrations of DSS were determined.

The

effect of DSS on peritoneal absorption of phenol red was also studied.
DSS was found to increase the gastrointestinal absorption of
both phenol red and sulfisoxazole.

It also increased the peritoneal

absorption of phenol red in the rat. Its effect was concentration
dependent.

The enhancement of drug absorption by this surfactant, DSS,

is postxilated to be due to a direct effect of surfactant on the biolog
ical membranes.

The decrease in absorption at higher concentrations

is postulated to be due to micellar entrapment of the drug by the DSS
micelles.
Polaxalene was foTond not to increase the gastrointestinal ab
sorption of phenol red.

But its higher concentrations decreased the

absorption of phenol red due to micellar entrapment.
Biopharmaceutical iiq)lications of the study were discussed.
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